Page last updated: 2024-08-24

epigallocatechin gallate and Disease Models, Animal

epigallocatechin gallate has been researched along with Disease Models, Animal in 295 studies

Research

Studies (295)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (0.34)	18.2507
2000's	41 (13.90)	29.6817
2010's	199 (67.46)	24.3611
2020's	54 (18.31)	2.80

Authors

Authors	Studies
El Alami, M; Giner, E; Giner, RM; Máñez, S; Recio, MC; Ríos, JL	1
Crawford, AD; Esguerra, CV; Franzblau, SG; Lauinger, IL; Maes, L; Perozzo, R; Pham, DH; Stairiker, C; Tarun, A; Tasdemir, D; Tonge, PJ; Vivas, L; Xu, H; Zhang, X; Zloh, M	1
Chen, GD; Feng, XL; Gao, H; Guo, LD; He, RR; Huang, Y; Li, XX; Yao, XS; Yu, Y; Zhao, Q; Zheng, YZ; Zhou, WX	1
Hara, Y; Kuramoto, A; Montenegro, JL; Nagano, F; Nakatsu, S; Shiraishi, C; Ukai, T; Yoshinaga, M; Yoshinaga, Y	1
Guo, N; Hao, K; Liu, C; Liu, Z	1
Hirai, C; Kan, T; Kurokawa, A; Masuda, S; Noaki, R; Shimamura, Y; Utsumi, M	1
Cui, Y; Liu, G; Wang, Y	1
Chen, JX; He, YL; Lin, WT; Wei, X; Xu, WX; Zeng, M	1
Han, X; Huang, L; Luo, X; Mao, Q; Peng, C; Wu, S; Zhang, H	1
Jang, M; Jung, W; Park, J; Park, R; Park, Y; Park, YI	1
Liu, L; Luo, M; Mou, Q; Tian, J	1
Fu, Y; Gao, Y; Li, P; Wang, Z; Wu, J; Wu, Z; Xu, S; Yu, Y; Yuan, Y; Zhou, L	1
Huang, X; Jia, Z; Liu, L; Luo, M; Mou, Q; Quan, J; Tian, J	1
Cao, Y; Liu, S; Ma, L; Ma, Y; Ramos-Mucci, L; Sun, J; Xiao, B; Yang, X; Zhang, J; Zhu, Z	1
Chang, HW; Chen, LC; Cheng, TC; Fang, CL; Ho, YS; Kuo, CC; Lee, WJ; Liao, YC; Lin, LC; Tu, SH; Yen, Y	1
Abdel-Moneim, AM; Abdelmeguid, NE; Hammad, TM; Salam, SA	1
Chen, SM; Li, WJ; Luo, YP; Tang, XF; Wu, Q; Zhang, YC	1
Li, X; Lv, H; Shi, F; Wang, W; Zhang, Z	1
Gong, Z; Qu, Q; Song, X; Xiao, W; Xu, W	1
Chen, H; Guo, J; Jin, S; Qin, T; Yao, D	1
Chen, L; Gan, X; Jian, J; Liang, R; Wang, R; Yu, Q; Zhang, N	1
Li, M; Weigmann, B	1
Chen, MH; Fang, W; Li, N; Qin, S; Qin, T; Tan, XF; Xie, L; Yang, YG	1
Gao, B; Guo, ZW; Li, YQ; Lu, MD; Wang, ZY; Xue, TC; Zhou, XH	1
Hochstetter, D; Mao, L; Wang, Y; Xu, P; Yao, L; Zhao, Y; Zhou, J	1
Dagli, AF; Gencoglu, H; Karatas, A; Koca, SS; Orhan, C; Ozgen, M; Sahin, K; Sahin, N	1
Dong, R; Wang, J; Wang, X; Wu, X; Yang, CS; Yang, L; Zhang, J; Zhang, Y; Zhang, Z	1
Chen, L; Gan, X; Jian, J; Liang, R; Yang, X; Zhang, C	1
Chang, KC; Fang, CH; Li, KY; Lin, YW; Soung, HS; Tsai, CC; Tseng, HC; Wang, MH; Yang, CC	1
Aral, M; Ergün, Y; Hedef, A; Kaya, E; Kılınç, M	1
Gao, Q; Granato, D; Hu, L; Kan, Z; Li, X; Peng, CY; Qian, F; Wang, D; Wang, T; Wang, Y	1
Dhir, A	1
Cui, J; Wu, Y	1
Li, Y; Wang, HL; Xiang, L; Xiao, G; Xiao, J; Xie, M; Xu, Y; Xue, J	1
Bao, J; Gui, YR; Liu, W; Long, GF; Shang, JT; Shu, XJ; Wu, MJ; Xiao, YF; Yang, YH; Zhou, HY	1
Chen, X; Ji, X; Li, J; Liu, S; Luo, D; Ma, X; Xu, J; Xu, X; Zhao, J; Zhu, X	1
Kang, JB; Koh, PO; Park, DJ	2
Abd Eldaim, MA; Abdallah, AEM; Abdel-Daim, MM; Abdelaziz, SAM; Abdul Rashid, S; Abdullah, AS; Abdullah, LC; Abramson, MJ; Ahmed, HB; Ahmed, MM; Ahn, YC; Alexander, DC; Ando, T; Angelone, AM; Anglani, F; Ap, Y; Arthanari, SK; Axelrad, C; Bai, S; Bakonyi, P; Barnes, E; Beckmann, NA; Bélafi-Bakó, K; Bennett, CM; Bestha, RM; Bitsch, RG; Bradley, CA; Bu, Y; Calò, LA; Cañedo-Villaroya, E; Carlson, L; Caruso, S; Casado-Flores, J; Ceol, M; Cesarino, I; Chen, IL; Chen, R; Chen, X; Chilvers, MI; Cho, WK; Choong, TSY; Conceição-Neto, N; Culver, EL; Dai, X; de Lama Caro-Patón, G; De Rosa, I; Del Prete, D; Dharmage, SC; Dimitriadis, E; Dittakavi, S; Dobrowolski, JC; Edin, S; Elgarawany, GE; Emam, HE; Emmens, RW; Erbas, B; Erwich, JJHM; Farghali, M; Feng, L; Funston, RN; Gabler, NK; Gale, P; Ganesh, M; Gao, J; Gao, L; Gao, X; García-Salido, A; Gatto, R; Gautam, S; Ge, C; Ghogomu, SM; Gianesello, L; Gonçales, VR; Gooch, JL; Gooding, JJ; Gourley, GG; Gu, H; Gu, X; Gu, Z; Guerreri, M; Guillén, M; Hazzaa, SM; Heylen, E; Hicks, R; Hong, X; Hoshi, M; Hu, B; Hu, LX; Hu, R; Hu, S; Huang, J; Huang, K; Hubbard, WB; Hui, J; Hwang, NY; Iannacci, J; Ianus, A; Iglesias-Bouzas, MI; Ihara, I; Iwasaki, M; Jaeger, S; Kandel, YR; Karpińska, G; Kim, HK; Klopfenstein, TJ; Knorr, D; Koók, L; Kotb, S; Kruithof, S; Larsson, P; Laurence, C; Leng, J; Li, H; Li, J; Li, Q; Li, S; Li, X; Li, Z; Lian, J; Liang, JX; Liang, X; Lighaam, LC; Lin, CW; Lin, HC; Lin, J; Ling, A; Liu, J; Liu, P; Liu, YS; Ljuslinder, I; Lo, GH; Lodge, CJ; Löfgren-Burström, A; Lowe, AJ; Lu, M; Lu, N; Lucero-Prisno, DE; Luebbe, KM; Luo, X; Ma, Z; Maes, P; Makuch, M; Malekbala, MR; Mao, Z; Martínez-Romera, I; Marzo, G; Mathew, FM; Mattei, A; Matthijnssens, J; Mayumi, M; Morita, N; Mueller, DS; Mullangi, R; Mummolo, S; Murthi, P; Myte, R; Nabeshima, T; Nakamoto, K; Nehdi, IA; Nemestóthy, N; Niessen, HWM; Noh, JM; Nota, A; Nunes, D; Oh, D; Öhlund, D; Olsen, KM; Ono, H; Osawa, Y; Palmqvist, R; Palombo, M; Park, M; Patience, JF; Peng, Y; Perng, DS; Persano, A; Priante, G; Prince, SJ; Pulipati, S; Pyo, H; Qiu, X; Quan, J; Quaranta, F; Quinzi, V; Rademacher, CJ; Rajaraman, G; Rashid, U; Rauch, JC; Rector, A; Remmerswaal, EBM; Ren, R; Rispens, T; Rocha, GS; Saad, NM; Saito, K; Salamova, A; Sarfaraz, K; Satoshi, A; Schnellmann, RG; Scholpa, NE; Schonhoff, M; Schwartz, KJ; Schwarze, M; Schweer, WP; Seiichi, Y; Serrano-González, A; Severino, J; Shemesh, N; Shi, ZQ; Shike, DW; Shim, YM; Siciliano, PA; Siebenrock, KA; Silva, MKL; Smith, DL; Soltani, S; Song, YM; Spry, ML; Stalker, LA; Stokes, RS; Sullivan, PG; Sun, JM; Sun, S; Svanes, C; Syo, K; Tai, CM; Takashima, S; Tashita, C; Taurino, A; Ten Berge, IJM; Tenuta, AU; Teo, SH; Tilley, RD; Trivedi, RK; Umetsu, K; Unger, PA; van Bruggen, R; van Ham, SM; Van Ranst, M; Vanitha, J; Vekaria, HJ; Venier, M; Venkateshwaran, K; Venkert, A; Vermeulen, E; Wan, C; Wang, H; Wang, N; Wang, P; Wang, T; Wang, X; Wang, Y; Wise, KA; Wolbink, GJ; Wu, J; Wu, P; Wu, S; Wu, Y; Xia, Q; Xin, W; Xiong, Q; Xu, H; Xu, P; Xue, S; Yamamoto, Y; Yamashiro, T; Yan, F; Yan, H; Yan, S; Yan, Y; Yang, JM; Yang, L; Yang, P; Ye, W; Yeh, JH; Yinda, CK; Ying, GG; Ying, L; Yoon, HG; Yu, H; Zainuddin, M; Zakkula, A; Zeller, M; Zeng, Y; Zha, J; Zhang, F; Zhang, H; Zhang, M; Zhang, Q; Zhang, S; Zhang, T; Zhang, Z; Zhao, C; Zhao, J; Zhao, Y; Zhong, Q; Zhu, J; Zingmark, C; Zo, JI; Zou, Y	1
Barroso, PA; Bracamonte, E; Korenaga, M; Marco, JD; Moya Álvarez, A; Sosa, AM	1
Alemany-González, M; Dierssen, M; Gener, T; Nebot, P; Puig, MV; Vilademunt, M	1
Berry, DL; Cheema, A; Chung, FL; Coia, H; Cruz, MI; Girgis, M; Hou, Y; Lee, Y; Ma, N; Pannkuk, E; Permaul, E; Rodriquez, O; Zhu, Z	1
Chen, X; Guo, H; Hao, S; He, R; Li, L; Li, Y; Lin, J; Lv, C; Shi, F; Song, X; Tang, H; Ye, G; Yin, Z; Zhao, L; Zou, Y	1
Goodlett, CR; LaCombe, J; Patel, R; Roper, RJ; Stringer, M; Wallace, JM	1
Lai, JY; Luo, LJ; Nguyen, DD	1
Li, H; Lv, L; Yang, F; Yuan, J	1
Chen, JY; Lu, JH; OuYang, D; Zhang, S; Zhu, Q	1
Li, G; Lin, W; Wang, X; Yang, J; Zheng, X; Zhou, C	1
Catuara-Solarz, S; De Toma, I; Dierssen, M; Ortega, M; Sabidó, E; Sierra, C	1
An, H; Cai, Z; Cao, J; Chen, N; Li, K; Li, Y; Luo, A; Peng, Y; Tang, Y; Tao, H	1
Ahn, SY; Cho, YK; Choi, C; Jung, YS; Kwon, SW; Lee, YH; Son, Y; Song, HD; Yoon, YC	1
Guo, H; Hao, S; He, R; Li, L; Li, Y; Shi, F; Song, X; Tang, H; Yan, Q; Ye, G; Zhao, L; Zou, Y	1
Heredia, M; Mollá, B; Sanz, P	1
Almeida-Toledano, L; Andreu-Fernández, V; Aras-López, R; García-Algar, Ó; Gómez-Roig, MD; Martínez, L	1
Diao, Y; Hu, X; Li, L; Li, X; Liu, H; Peng, J; Xu, Q; Yin, H; Yu, J; Zhang, C; Zhang, X; Zhang, Y	1
Albaigès, J; De La Torre, R; Dierssen, M; González, A; Gonzàlez, R; Llambrich, S; Martínez-Abadías, N; Sarlé, A; Sevillano, X; Sharpe, J; Starbuck, JM; Vande Velde, G; Wouters, J	1
Abunofal, O; Baig, S; Du, Y; Hicks, J; Mohan, C; Paglicawan, L; Soomro, S; Vanarsa, K	1
Ji, A; Li, J; Li, Y; Liu, Z; Wang, Y; Wu, D; Xie, Z; Zhang, Q; Zhong, P	1
Abd El-Fattah, AI; Abu-Elfotuh, K; Ali, AA; Elariny, HA	1
Cheng, L; Luo, ZL; Ren, JD; Sun, HY; Wu, XB	1
Kamal, DAM; Mokhtar, MH; Salamt, N; Zaid, SSM	1
Guo, Q; Sheng, DY; Xu, ST; Yang, P; Zhang, QZ	1
Guo, L; Guo, W; Jin, H; Li, T; Liu, X; Liu, Y; Song, Y; Sun, W; Wang, F; Wu, H; Wu, J; Yang, T; Zhang, H	1
Abeysekera, I; Dria, KJ; Goodlett, CR; LaCombe, J; Roper, RJ; Stancombe, K; Stewart, RJ; Stringer, M; Thomas, J; Wallace, JM	1
Bae, J; Hiroi, S; Huang, Y; Kangawa, K; Kumazoe, M; Nojiri, T; Onda, H; Tachibana, H; Takahashi, T; Takai, M; Takamatsu, K; Takeuchi, C; Tanaka, H; Yamada, S; Yamanouchi, M; Yamashita, S	1
Chen, Y; Guo, Y; Nan, Y; Wang, S; Wang, X; Zhao, Y	1
Fu, M; Fu, S; Hong, T; Liu, Y; Ni, S; Zou, L	1
Airoldi, C; Bonanomi, M; De Gioia, L; Gatta, E; Natalello, A; Pellistri, F; Penco, A; Regonesi, ME; Relini, A; Tortora, P; Vertemara, J; Visentin, C	1
Cheng, J; Jin, XL; Kim, J; Lao, WG; Lin, YG; Ong, M; Qu, XQ; Tan, Y; Xiao, L; Zhu, XQ	1
Hong, H; Li, Y; Su, B	1
Benov, L; Khan, KM; Renno, WM	1
Gao, H; Hu, Y; Li, X; Tian, R; Wang, Y; Williams, BR; Xu, P; Yan, F; Ying, L; Zhao, Y	1
Li, Y; Meeran, SM; Tollefsbol, TO	1
Carpes, FP; Garcia, A; Martins, A; Mello-Carpes, PB; Schimidt, HL	1
Azarnia, M; Mashayekhi, F; Salehi, Z; Semnani, M	1
Bimonte, S; Cascella, M; Cuomo, A; Mehrabi-Kermani, F; Schiavone, V	1
Almeida, L; Andreu-Fernández, V; Aras-López, R; Martínez, L; Tovar, J	1
Cai, X; Shang, Y; Yang, N; Zhang, H	1
Bhak, G; Lee, JT; Lee, S; Paik, SR; Park, JH; Rhoo, KY; Yang, JE	1
Honda, Y; Ichihara, E; Kiura, K; Kubo, T; Murakami, T; Ninomiya, T; Ochi, N; Takigawa, N; Tanimoto, M; Yamane, H; Yasugi, M	1
Cai, YK; Chen, J; Chen, WJ; Hao, Z; Lv, Y; Wang, HP; Wang, X; Ye, T; Zhao, JY	1
Liang, Z; Zhou, T; Zhu, M	1
Bing, X; Keyan, C; Linlang, L; Wanwei, D; Xuelei, L	1
Jung, UJ; Kim, SR	1
Govindaraj, S; Muhammed, I; Sankar, S	1
Chen, D; Wang, W; Zhu, K	1
Albericio, G; Borralleras, C; Bosch-Morató, M; Campuzano, V; Guivernau, B; Muñoz, FJ; Ortiz-Romero, P; Pérez-Jurado, LA	1
Chuang, SM; Ho, WT; Juan, YS; Lee, YC; Lee, YL; Lin, KL; Wu, BN; Wu, WJ	1
Chen, K; Chen, W; Han, Y; Hou, P; Huang, XY; Liu, SL; Qi, J; Wang, Y; Wu, TS; Yao, H; Yu, KF	1
Jimenez-Del-Rio, M; Martinez-Perez, DA; Velez-Pardo, C	1
Cai, M; Jiang, Q; Liu, Q; Wang, X; Wang, Y; Wu, R; Yao, Y	1
Alexandre, EC; André, DM; Antunes, E; Calixto, MC; Horimoto, CM	1
Chen, Q; Chen, Y; Gu, M; Liu, C; Wan, X; Wang, Z; Yang, T; Zhou, J	1
Zhang, G; Zhang, J	1
Guo, L; Li, J; Li, Q; Luo, X; Wu, G; Xi, J; Xue, H	1
Aggarwal, R; Chakrabarti, A; Kaur, H; Kumar, B; Medhi, B; Modi, M; Radotra, BD; Sinha, VR	1
Hahm, DH; Lee, B; Lee, H; Shim, I	1
Gan, Y; Liu, J; Liu, L; Tian, J; Zhao, W	1
Ding, L; Gao, X; Hu, J; Yu, S	1
Mao, L; Wang, Y; Xu, P; Zhou, J	1
Cai, H; Chen, S; Dai, J; Dong, F; Huang, YJ; Li, AL; Li, T; Li, WJ; Liu, X; Liu, ZG; Liu, ZS; Pang, X; Wang, M; Wang, X; Wu, SM; Xia, Q; Xia, T; Xing, JQ; Xue, W; Zhang, XM; Zhang, ZY; Zhao, M; Zhou, T	1
Chen, KH; Chen, ZY; Chiu, WY; Huang, HY; Lin, IC; Tseng, CL; Wang, MC; Wu, CC; Yang, WV	1
Ando, Y; Masuda, T; Misumi, Y; Ogura, T; Toyoshima, R; Tsuda, Y; Ueda, M; Yamanaka, K	1
Chen, Z; Jiang, Z; Li, Y; Liu, L; Lu, Z; Qing, H; Yang, Q; Zhang, L; Zhang, X	1
Koyama, N; Maeda, M; Mori, T; Segawa, T; Tan, J; Town, T	1
Gulati, A; Gupta, M; Kumari, A; Kumari, M; Padwad, Y; Sharma, A; Sharma, R	1
Casanova, E; Crescenti, A; Gibert-Ramos, A; Salvadó, J	1
Azuma, M; Dat Le, T; Hiraki, N; Inoue, YH; Omura, F; Yamanaka, M; Yoshimoto, Y	1
Eisenstein, M	1
Chan, SO; Chu, KO; Chu, WK; He, JN; Hui, WK; Li, J; Ng, TK; Pang, CP; Ren, J; Yip, YWY; Yu, QX	1
He, L; Liu, G	1
Cui, Z; Jia, L; Qu, Z; Si, P; Sun, C; Wang, W; Xie, T; Xue, Y; Zhen, J	1
Chevalier, C; Créau, N; Dairou, J; Daubigney, F; Delabar, JM; Duchon, A; Gu, Y; Herault, Y; Janel, N; Nalesso, V; Souchet, B; Yu, Y	1
Auladell, C; Barenys, M; Barroso, E; Camins, A; Cano, A; Chang, JH; Espina, M; Ettcheto, M; Folch, J; García, ML; Kühne, BA; Souto, EB; Turowski, P	1
Cortés, MJ; Cuenca-Royo, A; de la Torre, R; de Sola, S; Del Hoyo, L; Dierssen, M; Espadaler, JM; Esteba, S; Farré, M; Gomis-González, M; Hernandez, G; Langohr, K; León, A; Martínez-Leal, R; Milá, M; Novell, R; Ozaita, A; Rodriguez, J; Sánchez-Gutiérrez, J; Xicota, L	1
Shang, YX; Yang, N	1
Almudimeegh, S; Berwick, DC; Cleverley, K; Fisher, EMC; Granno, S; Harvey, K; Heaton, G; Nagda, Z; Nixon-Abell, J; Plagnol, V; Rain, JC; Tosh, J; Tybulewicz, VLJ; Wiseman, FK; Zanda, M	1
An, Y; Chang, Y; Cheng, J; Dang, H; Feng, J; Guo, H; Luo, K; Ma, C; Qiao, L; Shao, H; Tian, J; Xie, L; Xing, W; Yang, J; Yuan, Y	1
Cho, YY; Kang, HC; Lee, HE; Lee, HS; Lee, JY; Park, YB; Yang, G	1
Fan, SM; Wang, J; Zhang, J	1
Baig, S; Ding, H; Du, Y; Hicks, J; Mohan, C; Soomro, S; Vanarsa, K	1
Andrade, JP; Assunção, M; Cardoso, A; Carvalho, F; Lukoyanov, N; Rodrigues, J	1
Bishayee, A; Darvesh, AS	1
Czernizer, E; Dardik, A; Dardik, H; Hoffmann, T; London, D; Naftalovich, R; Orozco-Sevilla, V; Yang, C	1
Cai, Y; Hashizume, T; Kurita-Ochiai, T; Yamamoto, M	1
He, M; Liu, MY; Tang, QS; Wang, S; Wei, MJ; Yao, WF; Zhao, HS	1
Cao, YP; Han, K; Jia, N; Kong, JJ; Ren, GR; Sha, S; Zhang, XM	1
Chen, Y; Guo, SW; Liu, X; Zhang, H; Zhu, B	1
Diao, Y; Ge, R; Tao, L; Xiong, XC; Yuan, W; Zhu, Y	1
Benejam, B; Bizot, JC; Blehaut, H; Catuara, S; Covas, MI; Cuenca, A; De la Torre, R; de Lagran, MM; De Sola, S; Delabar, JM; Dierssen, M; Duchon, A; Farré, M; Fitó, M; Herault, Y; Janel, N; Langohr, K; Pons, M; Pujadas, M; Rodriguez, J	1
Jang, JY; Jeon, YK; Kim, CW; Lee, JK	1
Hollingsworth, A; Khurana, S; Piche, M; Tai, TC; Venkataraman, K	1
Chen, F; Lin, Y; Liu, G; Yao, C; Zhang, J	1
Jankun, J; Keck, RW; Selman, SH	1
Bisch, F; Derossi, S; Dickinson, D; Hahn, E; Hsu, S; Ma, YH; Ohno, S; Thomas, C; Yamamoto, T; Yates, N; Yu, H	1
Guo, Y; Jiang, L; Liu, D; Zhang, X; Zheng, C	1
Date, F; Mori, S; Ono, M; Saito, K	1
Goda, T; Mochizuki, K; Suzuki, T; Uchiyama, Y	1
Bianchi, DW; Delabar, JM; Guedj, F	1
Krishnan, TR; Mangaiah, S; Murugaiyan, U; Periandavan, K; Srinivasan, A; Vadivel, SK; Velusamy, P	1
Chung, SK; Koh, CH; Lee, HS	1
Feng, Z; Liu, J; Long, J; Tang, Y	1
Al-Maghrebi, M; Khraishah, H; Rao, MS; Renno, WM	1
Pan, J; Xu, X; Zhou, X	1
Bonanomi, M; Colombo, G; Cornelli, G; Doglia, SM; Malabarba, MG; Natalello, A; Pastori, V; Penco, A; Regonesi, ME; Relini, A; Tortora, P; Visentin, C	1
Chan, KP; Chan, SO; Chu, KO; Li, WY; Pang, CP; Qin, YJ; Ren, JL; Yang, YP; Yip, YW	1
Li, Q; Lin, F; Wang, S; Xu, A; Zhu, Y	1
Acquas, E; Arote, S; Cotti, E; Gaikar, M; Kasture, SB; Kasture, V; Rosas, M; Salve, B	1
Chen, B; Hu, Z; Jiang, B; Liu, G; Pei, F; Song, J; Yang, X; Zou, P	1
Huang, CY; Li, GT; Pan, JH	1
Ajit, D; Klakotskaia, D; Schachtman, TR; Serfozo, P; Simonyi, A; Sun, GY; Walker, JM; Weisman, GA; Wood, WG	1
Brown, WT; Meeker, HC; Ramakrishna, N	1
Tagami, M; Yamagata, K; Yamori, Y	1
Choudhury, M; Cobelli, NJ; Goldring, MB; Hanstein, R; Hardin, JA; Hirsh, DM; Kim, SJ; Leong, DJ; Majeska, RJ; Schaffler, MB; Spray, DC; Sun, HB	1
Dähnert, I; Dhein, S; Einenkel, A; Grassl, M; Kiefer, P; Kühne, L; Salameh, A; Vollroth, M; von Salisch, S	1
Bian, X; Du, F; Liu, N; Su, X; Sun, G; Wang, B; Wang, Y; Zhou, G	1
Chang, KC; Lin, RF; Soung, HS; Tsai, CC; Tseng, HC; Wang, MH	1
Chen, B; Hao, Q; Hu, Z; Jiang, B; Li, X; Liu, G; Yang, X; Zou, P	1
Al-Abbad, J; Al-Ali, W; Ali, H; Asfar, S; Dashti, A; Dashti, H; Jamal, MH; Mathew, C	1
Arumuggam, N; Bhowmick, NA; Rupasinghe, HP	1
Chen, J; Chen, T; Du, L; Li, J; Liu, P; Peng, S; Song, H; Wang, M; Xu, J	1
Date, F; Hong, G; Mori, S; Saito, K	1
Lu, M; Wu, LQ	1
Chang, X; Chen, Y; Cheng, S; Dun, W; Fang, S; Gu, X; He, W; Hou, X; Hu, Q; Liu, S; Mo, Y; Rong, C; Su, R; Wang, Q; Yang, C; Zhang, C; Zhang, L	1
Deng, YP; Gan, L; Guo, JQ; Li, H; Lu, XC; Luo, BD; Meng, ZJ; Xiong, RB; Zheng, ZW; Zou, F	1
Feng, X; Shen, K; Su, R; Xie, H; Zheng, S; Zhou, L	1
Chen, Y; Deng, Y; Ding, Y; Qian, K; Sun, X	1
Akdag, R; Alagoz, F; Belen, AD; Cetinalp, NE; Dalgic, A; Divanlioglu, D; Guvenc, Y; Helvacioglu, F; Koksal, I; Take, G; Yildirim, AE	1
Chen, ZS; He, F; Yang, J; Zhang, X	1
Feng, ZP; Guo, J; Kang, YM; Li, HB; Liu, JJ; Qi, J; Shi, T; Shi, XL; Su, Q; Wang, ML; Yi, QY; Yu, XJ; Zhang, DM; Zhang, Y; Zhu, GQ	1
Abeysekera, I; Blazek, JD; Li, J; Roper, RJ	1
Tang, CB; Wang, S; Zhou, Y	1
D'Angelo, J; Li, J; Li, W; Wang, H; Wu, AH; Wu, R; Zhu, S	1
de la Torre, R; Dierssen, M; Rodriguez-Morato, J; Xicota, L	1
Burton, DR; Douglas, D; Egli, A; Forester, S; Houghton, M; Humar, A; Kneteman, N; Lambert, J; Law, J; Law, M; Lund, G; O'Shea, D; Tyrrell, DL	1
Bongen, P; Brener, O; Demuth, HU; Dunkelmann, T; Funke, SA; Gremer, L; Hoyer, W; Janssen, A; Jürgens, D; Kadish, I; Kutzsche, J; Langen, KJ; Mirecka, EA; Nagel-Steger, L; Oesterhelt, F; Pietruszka, J; Rudolph, S; Tusche, M; van Groen, T; Willbold, D; Willuweit, A	1
Chung, WY; Ko, TH; Li, TS; Lin, JH; Lin, YH; Wang, SH; Yao, CH	1
Ahmed, S; Chourasia, M; Riegsecker, S; Singh, AK; Umar, S	1
Huang, J; Wang, Y; Yang, CS; Zhang, J; Zhang, L	1
Funamoto, M; Hyon, SH; Ikeda, T; Masumoto, H; Minakata, K; Sakata, R; Setozaki, S; Takaori, K; Taki, T; Yamazaki, K	1
Abeysekera, I; Berman, AG; Dria, KJ; Georgiadis, TM; Hammond, MA; Roper, RJ; Thomas, J; Wallace, JM	1
Janakiram, NB; Kumar, G; Madka, V; Mohammed, A; Rao, CV	1
You, YP	1
Aksakal, İA; Demir, A; Engin, MS; Keleş, MK; Küçüker, İ; Önger, ME	1
Sanna, V; Siddiqui, IA	1
Chang, KC; Chen, CN; Lin, RF; Shih, RL; Soung, HS; Tsai, CC; Tseng, HC; Wang, MH	1
Cho, ML; Jung, YO; Kim, EK; Kim, HY; Kwon, JE; Lee, SH; Lee, SY; Oh, HJ; Park, MK; Park, SH; Ryu, JG; Son, HJ	1
Contestabile, A; de Bari, L; de Rasmo, D; Henrion-Caude, A; Signorile, A; Vacca, RA; Valenti, D	1
Aguilera Olvera, R; Joe, B; Kennett, MJ; Lambert, JD; Singh, V; Vijay-Kumar, M; Xiao, X; Yeoh, BS	1
Bona, G; Buonpensiero, P; De Gregorio, F; De Rosa, G; De Stefano, D; Di Pasqua, A; Esposito, S; Ferrari, E; Grassia, R; Guido, S; Kroemer, G; Leone, CA; Lusa, S; Maiuri, L; Maiuri, MC; Mehta, A; Raia, V; Salvadori, L; Sana, I; Sepe, A; Stoll, G; Tosco, A	1
Bayliss, R; Brown, K; Gescher, A; Howells, L; Karmokar, A; Khan, S; Thomas, AL	1
Cho, WJ; Han, JY; Jung, YD; Kim, JH; Kim, JK; Lee, SG; Oh, BS	1
Bitzer, ZT; Elias, RJ; Lambert, JD; Vijay-Kumar, M	1
Jian, J; Xuan, F	1
Ishizaki, Y; Kikuzaki, H; Kobayashi, K; Kojo, S	1
Heidor, R; Moreno, FS; Pogribny, IP	1
Chen, KH; Chen, ZY; Fang, HW; Hung, YJ; Tseng, CL	1
Chen, J; Song, H	1
Botelho, PB; de Morais, AC; Ferreira, MA; Mota, JF; Silva, DM	1
Bai, L; Chen, J; Jin, L; Li, M; Liang, Z; Lu, C; Lu, L; Tang, H; Tang, L; Wang, K; Wu, R; Yan, Y; Ye, Y	1
Bartesaghi, R; Ciani, E; Emili, M; Giacomini, A; Guidi, S; Rimondini, R; Sassi, M; Stagni, F; Trazzi, S	1
Gelling, RW; Han, W; Kek, HC; Li, H; Lim, J	1
Hirao, S; Ikeda, T; Kuwahara, K; Masumoto, H; Minakata, K; Sakata, R; Setozaki, S; Yamazaki, K	1
Kalinovsky, T; Niedzwiecki, A; Rath, M; Roomi, MW	1
Guo, LL; Jin, HM; Pan, Y; Yang, XH; Zhan, XL; Zhang, BL	1
Hwang, S; Jun, DY; Kim, SH; Lee, J; Lee, SG; Park, GC; Song, GW; Tak, E	1
Bai, Q; Dong, T; Lou, J; Lyu, Z; Pan, Z; Yang, X	1
McGeary, A; Penack, O; Rudloff, S; Westphal, S; Wilke, A	1
Chang, CY; Chen, KH; Chen, ZY; Lin, FH; Liu, GS; Miyagawa, T; Tseng, CL; Wang, MC	1
Adhami, VM; Chamcheu, JC; Jashari, R; Mukhtar, H; Rady, I; Sanna, V; Sechi, M; Siddiqui, IA; Singh, CK	1
Blazek, JD; Ghoneima, A; Harrington, E; Kula, K; McElyea, SD; Roper, RJ; Starbuck, JM; Tumbleson-Brink, DM	1
Baek, SJ; Eling, TE; Hara, Y; Lee, SH; McEntee, MF; Sukhthankar, M; Yamaguchi, K	1
Biao, W; Horiuchi, M; Jun, L; Kumagai, S; Kurosaka, M; Morinobu, A; Sakai, Y; Tanaka, S; Tsuji, G	1
Ahmed, S; Campbell, PL; Koch, AE; Kwan, K; Marotte, H; Pakozdi, A; Rabquer, BJ; Ruth, JH	1
Bisch, F; Camba, AM; Chu, TC; Dickinson, DP; Gillespie, K; Hsu, SD; Kodani, I; Looney, S; Ogbureke, KU; Qin, H; Schuster, GS; Sharawy, M; Wu, M	1
Akdemir, F; Kucuk, O; Onderci, M; Ozercan, IH; Sahin, K; Sahin, N; Seren, S	1
Gu, ZL; Guo, CY; Sheng, R; Xie, ML; Zhou, WX	1
Chen, MH; Hong, CY; Hou, KL; Kok, SH; Lee, YL; Lin, SK; Lin, YT; Wang, CC	1
Chen, DD; Dong, YG; He, JG; Liu, D	1
Kumar, A; Kumar, P	2
Chopra, K; Kuhad, A; Sachdeva, AK; Tiwari, V	1
Au, AY; Frondoza, CG; Grzanna, MW; Heinecke, LF; Mochal, CA; Rashmir-Raven, A	1
Geraldine, P; Ramesh, E; Thomas, PA	1
Bae, HB; Jeong, CW; Kim, HS; Kim, JP; Kim, SJ; Kim, WM; Kwak, SH; Lee, HG; Li, M	1
Hua, H; Jiang, Y; Jing, J; Li, M; Luo, T; Sun, X; Wang, J; Yin, Y; Zhang, Y	1
Arora, V; Chopra, K; Kuhad, A; Sachdeva, AK; Tiwari, V	1
Amit, T; Kalfon, L; Mandel, SA; Reznichenko, L; Youdim, MB	1
Chung, ME; Hong, BY; Im, S; Kim, HS; Kim, HW; Kim, TM; Kim, YK; Ko, YJ; Lee, JI; Lim, SH	1
Delabar, JM	1
Li, H; Yang, P	1
Chen, F; Jiang, L; Jin, Y; Xie, J; Yang, D; Zhang, T	1
Jeon, BS; Kim, JM; Kim, JS; O, JJ	1
Hong, JT; Lee, MK; Lee, YM; Oh, JH; Oh, KW; Park, KS; Yoo, HS	1
Chopra, K; Kuhad, A; Tiwari, V	1
Guo, D; Guo, S; Hu, Y; Liao, H; Liu, P; Wang, D; Wang, Y	1
Fernandez, JW; Obregon, D; Rezai-Zadeh, K; Tan, J	1
Azuma, T; Ekuni, D; Endo, Y; Irie, K; Maruyama, T; Morita, M; Tamaki, N; Tomofuji, T; Yamamoto, T	1
Bian, JS; Bin Sattar, MM; Huang, Y; Lee, HC; Zheng, J	1
Chen, TC; Golden, EB; Hofman, FM; Louie, SG; Schönthal, AH; Sivakumar, W; Thomas, S; Wang, W	1
Kannaiyan, R; Sethi, G; Shanmugam, MK	1
Alcorn, JF; Craigo, JK; Kolls, JK; Qin, S; Reinhart, TA; Tarwater, PM; Tjoeng, C	1
Adhikary, B; Bandyopadhyay, SK; Chattopadhyay, S; Yadav, SK	1
Jin, XF; Liu, Q; Ran, ZH; Tong, JL; Xiao, SD; Xu, Q; Xu, XT; Yang, CH	1
Keck, RW; Selman, SH	1
Chen, YK; Cheung, C; Lee, MJ; Liu, AB; Lu, YP; Reuhl, KR; Yang, CS	1
Kang, H; Kim, HO; Kim, HS; Kim, MH; Kim, YY; Park, YM; Up No, S	1
Chauhan, SK; Dana, R; Lee, HS; Nallasamy, N; Okanobo, A	1
Chen, CH; Chuang, SM; Huang, CH; Juan, YS; Levin, RM; Liu, KM; Long, CY	1
Choi, JI; Kim, WM; Kim, YO; Lee, HG; Yoon, MH	1
Almeida, MR; Ferreira, N; Saraiva, MJ	1
Dorchies, OM; Nakae, Y; Ritter, C; Ruegg, UT; Stoward, PJ; Zimmermann, BF	1
Chang, WC; Chuang, SM; Huang, CH; Juan, YS; Lee, YL; Levin, RM; Liu, KM; Long, CY; Wu, TH	1
Guan, F; Ju, J; Li, G; Liu, AB; Sun, Y; Yang, CS; Yang, Z	1
Chiba, M; Kawano, S; Nakagami, T; Sanada, Y; Sugiyama, A; Tajiri, T; Toki, A	1
Awwad, J; Bazi, T; Hajj-Hussein, IA; Hijaz, M; Jurjus, A; Shams, A	1
Chu, TC; Derossi, S; Dickinson, D; Hsu, S; Ogbureke, K; Ohno, S; Yamamoto, T; Yu, H	1
Choi, DY; Han, SB; Hong, JT; Lee, YJ; Oh, KW; Yun, YP	1
He, M; Huang, Q; Huang, R; Liao, M; Lin, X; Wei, L; Zhang, S; Zheng, L; Zhuo, L	1
Barañao, RI; Bastón, JI; Bilotas, MA; Meresman, GF; Olivares, CN; Ricci, AG; Singla, JJ	1
da Silva, EL; Hort, MA; Maraschin, M; Minatti, J; Ribeiro-do-Valle, RM; Wazlawik, E; Zaleski, FL	1
Cai, Y; Chen, TT; Gao, S; Geng, B; Liu, PQ; Ye, JT; Yu, SS; Yu, Y	1
Hashimoto, S; Imano, M; Ito, A; Itoh, T; Matsuo, K; Mizuguchi, N; Munakata, H; Nakayama, T; Nishida, S; Satou, T; Tabuchi, M; Tsubaki, M	1
Sui, FX; Teng, X; Wu, YB; Yu, JF; Zhao, CG; Zhou, P	1
Imamura, M; Itami, A; Kaganoi, J; Kawabe, A; Komoto, I; Li, ZG; Maeda, M; Sato, F; Shimada, Y	1
Jung, JG; Kim, CY; Lee, JJ; Lee, SR; Lee, SY	1
Beissenhirtz, M; Büttemeyer, R; Lisdat, F; Mall, JW; Philipp, AW; Schlenzka, L	1
Amit, T; Mandel, S; Weinreb, O; Youdim, MB	1
Albini, A; Calabrese, F; Dell'Aica, I; Donà, M; Garbisa, S; Morini, M; Pezzato, E; Sartor, L	1
Mandel, S; Maor, G; Youdim, MB	1
Campbell, C; Chavin, KD; Cheng, G; Donovan, JL; Evans, Z; Fiorini, RN; Haines, JK; Markowitz, JS; May, HD; Milliken, CE; Rodwell, D; Schmidt, MG	1
Banerjee, S; Das, S; Ganguly, C; Manna, S; Panda, CK; Saha, P	1
Hwang, MS; Kim, HT; Kim, HY; Kim, J; Kim, MH; Kim, OH; Kim, SH; Koh, SH; Lee, KW; Lee, KY; Lee, SM; Lee, YJ; Song, C; Yang, KW	1
Buetler, TM; Dorchies, OM; Kucera, P; Ruegg, UT; Vuadens, O; Wagner, S; Waldhauser, K	1
Chang, KW; Hsu, HC; Ko, SY; Lin, SC; Liu, TY	1
Choi, IW; Kim, SH; Lee, CM; Lee, HK; Moon, DO; Park, HJ; Park, YM; Roh, HJ	1
Bani, D; Ciampa, A; Giannini, L; Masini, E; Menegazzi, M; Nistri, S; Suzuki, H; Suzuki, Y	1
Guiramand, J; Lanté, F; Maurice, T; Nedjar, M; Récasens, M; Thethi, K; Vignes, M	1
Choi, MS; Jang, YH; Kim, AR; Kim, JM; Lee, MY; Lee, SR; Lee, YC; Mun, KC; Park, HR; Park, NH; Shin, HY	1
Chen, S; Le, W; Li, L; Li, X; Luo, G; Xu, Z	1
Chiba, T; Fukuzawa, Y; Hirai, M; Hotta, Y; Ishikawa, N; Isobe, F; Kawamura, N; Nakano, A; Wakida, Y	1
Aktas, O; Waiczies, S; Zipp, F	1
Bollag, WB; Borke, J; Camba, AM; Dickinson, DP; Hsu, SD; Ogbureke, KU; Qin, H; Schuster, GS; Sharawy, MM; Stöppler, HJ; Winger, JN	1
Cao, LQ; Chen, XL; Huang, XH; Li, W; Liu, YJ; Sun, K; Wang, Q; Zhang, LJ; Zhen, MC	1
Catravas, JD; Denenberg, AG; Hake, PW; Lahni, PM; Snead, C; Wheeler, DS; Wong, HR; Zingarelli, B	1
Egashira, N; Egawa, T; Fujiwara, M; Irie, K; Iwasaki, K; Kitamura, Y; Mishima, K; Motohashi, K; Orito, K; Pu, F; Tanaka, Y	1
Camino, A; Esteva, MI; Flawiá, MM; Güida, MC; Paveto, C; Torres, HN	1
Bahcecioglu, IH; Dagli, AF; Kuzu, N; Ozercan, IH; Sahin, K; Ustündag, B	1
Ju, J; Lambert, JD; Lu, G; Yang, CS	1
Abboud, PA; Burroughs, TJ; Hake, PW; Mangeshkar, P; O'Connor, M; Odoms, K; Wong, HR; Zingarelli, B	1
Chen, Y; Lin, YZ; Song, YG	1
Devika, PT; Prince, PS	1
Joghataie, MT; Nobakht, M; Rasoolijazi, H; Roghani, M	1
Arendash, GW; Fernandez, F; Hou, H; Jensen, M; Rezai-Zadeh, K; Runfeldt, M; Shytle, RD; Tan, J	1
de Villiers, WJ; McClain, CJ; Varilek, GW; Yang, F	1

Reviews

25 review(s) available for epigallocatechin gallate and Disease Models, Animal

Article	Year
Natural polyphenols in preclinical models of epilepsy. Phytotherapy research : PTR, 2020, Volume: 34, Issue:6 Topics: Animals; Catechin; Disease Models, Animal; Epilepsy; Humans; Male; Polyphenols; Quercetin; Rats; Rats, Sprague-Dawley; Resveratrol	2020
Computational & theoretical chemistry, 2013, Feb-01, Volume: 1005 Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Amylose; Anaerobiosis; Animals; Anti-Bacterial Agents; Anura; Arginase; Arthritis, Rheumatoid; Asthma; Atmosphere; B-Lymphocytes; Basic Helix-Loop-Helix Transcription Factors; Bioelectric Energy Sources; Biofilms; Biofuels; Biomarkers; Biopolymers; Bioreactors; Brain; Brain Injuries, Traumatic; Breast Neoplasms; Calibration; Carbon Tetrachloride; Caspase 3; Catalysis; Catechin; Cations; Cattle; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Body; Cell Line, Tumor; Cell Plasticity; Chemical and Drug Induced Liver Injury; Chemistry Techniques, Synthetic; China; Chitosan; Chloride Channels; Chromatography, High Pressure Liquid; Chromosome Mapping; Cognition; Cognitive Dysfunction; Cohort Studies; Colitis, Ulcerative; Colloids; Coloring Agents; Congresses as Topic; Correlation of Data; Crystallization; Cyanoacrylates; Cyclohexane Monoterpenes; Cyprinidae; Cytochrome P-450 CYP1A1; Death, Sudden; Dent Disease; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Disease Progression; Disease Resistance; Disulfides; Drug Monitoring; Drug Stability; Ecotoxicology; Electricity; Electrodes; Endocytosis; Environmental Exposure; Environmental Monitoring; Enzyme Inhibitors; Epithelial-Mesenchymal Transition; Esophageal and Gastric Varices; Esters; Fagopyrum; Female; Ferrosoferric Oxide; Flame Retardants; Flavobacteriaceae; Flow Cytometry; Follow-Up Studies; Formoterol Fumarate; Fusarium; Garlic; Gastrointestinal Hemorrhage; Gene Expression; Genes, Plant; Genetic Markers; Glial Fibrillary Acidic Protein; Gliosis; Global Health; Glutathione Transferase; Glycine max; Gum Arabic; Hemostasis, Endoscopic; Hepatocytes; Hippocampus; Humans; Hydrogen-Ion Concentration; Illinois; Immunoglobulin G; Indoleamine-Pyrrole 2,3,-Dioxygenase; Infant, Newborn; Infant, Small for Gestational Age; Injections, Intraperitoneal; Interleukin-4; Iowa; Iron; Ki-67 Antigen; Kidney; Kinetics; Kynurenine; Lakes; Levofloxacin; Lipid Peroxidation; Lipids; Liver; Liver Cirrhosis, Experimental; Magnetic Fields; Magnetic Iron Oxide Nanoparticles; Male; Manure; Maze Learning; Memory, Short-Term; Metal Nanoparticles; Metals, Heavy; Methane; Mice; Mice, Inbred C57BL; Mice, Knockout; Michigan; Microalgae; Microbial Consortia; Mitochondria; Models, Animal; Models, Chemical; Models, Neurological; Molecular Structure; Molecular Weight; Mutation; Myeloid-Derived Suppressor Cells; NADPH Oxidase 2; Neoplasm Recurrence, Local; Neurites; Neurons; Neuroprotective Agents; NF-kappa B; NIH 3T3 Cells; Nitric Oxide Synthase Type II; Nitrogen; Ohio; Ointments; Ontario; Organelle Biogenesis; Organophosphates; Organophosphorus Compounds; Oxidative Stress; Palladium; Particle Size; Pectins; Phenotype; Phytotherapy; Piperidines; Placenta; Plant Diseases; Plant Extracts; Polymers; Polymorphism, Genetic; Polyphenols; Powders; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Protein Kinase Inhibitors; Protein Structure, Secondary; Proteins; Pyridines; Pyrimidines; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptors, Aryl Hydrocarbon; Receptors, Chemokine; Receptors, Formyl Peptide; Receptors, Lipoxin; Recovery of Function; Recurrence; Reference Standards; Reference Values; Reproducibility of Results; Respiratory Function Tests; Retrospective Studies; Risk; Sensitivity and Specificity; Sewage; Signal Transduction; Sodium Glutamate; Soil; Solanum tuberosum; Solubility; Solutions; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spermatozoa; STAT3 Transcription Factor; Sulfamethoxazole; Tea; Temperature; Thermodynamics; Thrombin; Treatment Outcome; Triazoles; United States; Viscosity; Waste Disposal, Fluid; Wastewater; Water; Water Pollutants, Chemical; Water Purification; White Matter; Wisconsin; X-Ray Diffraction; Zea mays	2013
The pharmacological activity of epigallocatechin-3-gallate (EGCG) on Alzheimer's disease animal model: A systematic review. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2020, Volume: 79 Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Animals; Antioxidants; Blood-Brain Barrier; Catechin; Cognition; Disease Models, Animal; Humans; Neuroprotective Agents; Phosphorylation	2020
Beneficial Effects of Green Tea Catechins on Female Reproductive Disorders: A Review. Molecules (Basel, Switzerland), 2021, May-03, Volume: 26, Issue:9 Topics: Angiogenesis Inhibitors; Animals; Antioxidants; Apoptosis; Camellia sinensis; Catechin; Cell Proliferation; Corticosterone; Cross-Sectional Studies; Disease Models, Animal; Dysmenorrhea; Endometriosis; Female; Humans; Mice; Plant Extracts; Polycystic Ovary Syndrome; Tea; Uterus	2021
The roles of epigallocatechin-3-gallate in the treatment of neuropathic pain: an update on preclinical in vivo studies and future perspectives. Drug design, development and therapy, 2017, Volume: 11 Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Camellia sinensis; Catechin; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Neuralgia	2017
Beneficial Effects of Flavonoids Against Parkinson's Disease. Journal of medicinal food, 2018, Volume: 21, Issue:5 Topics: Animals; Anthocyanins; Antioxidants; Antiparkinson Agents; Catechin; Cell Line; Corpus Striatum; Disease Models, Animal; Dopamine; Flavanones; Flavones; Flavonoids; Flavonols; Humans; Isoflavones; Kaempferols; Neuroprotective Agents; Oxidative Stress; Parkinson Disease	2018
Epigallocatechin Gallate Modulates Muscle Homeostasis in Type 2 Diabetes and Obesity by Targeting Energetic and Redox Pathways: A Narrative Review. International journal of molecular sciences, 2019, Jan-27, Volume: 20, Issue:3 Topics: Animals; Catechin; Diabetes Mellitus, Type 2; Disease Models, Animal; Energy Metabolism; Epigenesis, Genetic; Glucose; Homeostasis; Humans; Lipid Metabolism; Muscle, Skeletal; NF-kappa B; Obesity; Oxidative Stress; Signal Transduction	2019
Chemopreventive and therapeutic potential of tea polyphenols in hepatocellular cancer. Nutrition and cancer, 2013, Volume: 65, Issue:3 Topics: Animals; Anti-Inflammatory Agents; Anticarcinogenic Agents; Antioxidants; Biological Availability; Catechin; Chemoprevention; Disease Models, Animal; Humans; Liver Neoplasms; Mice; Polyphenols; Tea; Xenograft Model Antitumor Assays	2013
Polyphenols: benefits to the cardiovascular system in health and in aging. Nutrients, 2013, Sep-26, Volume: 5, Issue:10 Topics: Aging; Animals; Cardiovascular System; Catechin; Curcumin; Diet; Disease Models, Animal; Fruit; Heart Diseases; Humans; Olive Oil; Plant Oils; Polyphenols; Quercetin; Randomized Controlled Trials as Topic; Reactive Oxygen Species; Resveratrol; Stilbenes	2013
Prenatal treatment of Down syndrome: a reality? Current opinion in obstetrics & gynecology, 2014, Volume: 26, Issue:2 Topics: Animals; Animals, Newborn; Apigenin; Catechin; Choline; Disease Models, Animal; Down Syndrome; Dyrk Kinases; Female; Fluoxetine; Humans; Mice; Mice, Transgenic; Molecular Targeted Therapy; Neural Stem Cells; Neurogenesis; Neuroprotective Agents; Oxidative Stress; Pregnancy; Prenatal Care; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, GABA; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Stem Cell Transplantation	2014
Dietary polyphenols regulate endothelial function and prevent cardiovascular disease. Nutrition (Burbank, Los Angeles County, Calif.), 2015, Volume: 31, Issue:1 Topics: Administration, Oral; Animals; Apigenin; Aryldialkylphosphatase; Cardiovascular Diseases; Catechin; Diet; Disease Models, Animal; Endothelial Cells; Endothelin-1; Humans; Lipoproteins, HDL; Nitric Oxide; Nitric Oxide Synthase Type III; Polyphenols; Signal Transduction; U937 Cells	2015
A Review: Phytochemicals Targeting JAK/STAT Signaling and IDO Expression in Cancer. Phytotherapy research : PTR, 2015, Volume: 29, Issue:6 Topics: Animals; Catechin; Cell Proliferation; Cucurbitacins; Curcumin; Disease Models, Animal; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Janus Kinases; Neoplasms; Phytochemicals; Resveratrol; Signal Transduction; STAT Transcription Factors; Stilbenes	2015
Potential Role of (-)-Epigallocatechin-3-Gallate (EGCG) in the Secondary Prevention of Alzheimer Disease. Current drug targets, 2017, Volume: 18, Issue:2 Topics: Alzheimer Disease; Animals; Catechin; Clinical Trials as Topic; Disease Models, Animal; Humans; Neuroprotective Agents; Oxidative Stress; Secondary Prevention; Treatment Outcome	2017
Mechanisms of body weight reduction and metabolic syndrome alleviation by tea. Molecular nutrition & food research, 2016, Volume: 60, Issue:1 Topics: Adipose Tissue; AMP-Activated Protein Kinases; Animals; Camellia sinensis; Cardiovascular Diseases; Catechin; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Liver; Meta-Analysis as Topic; Metabolic Syndrome; Muscle, Skeletal; Plant Leaves; Polyphenols; Randomized Controlled Trials as Topic; Risk Factors; Tea; Weight Loss	2016
Prevention and treatment of cancers by immune modulating nutrients. Molecular nutrition & food research, 2016, Volume: 60, Issue:6 Topics: Animals; Arginine; Catechin; Cell Line, Tumor; Diet; Disease Models, Animal; Fatty Acids, Unsaturated; Glutamine; Humans; Isothiocyanates; Lignans; Meta-Analysis as Topic; Micronutrients; Neoplasms; Observational Studies as Topic; Phytochemicals; Polyphenols; Randomized Controlled Trials as Topic; Stilbenes	2016
Impact of nanotechnology on the delivery of natural products for cancer prevention and therapy. Molecular nutrition & food research, 2016, Volume: 60, Issue:6 Topics: Animals; Anticarcinogenic Agents; Biological Products; Catechin; Cell Line, Tumor; Chemoprevention; Curcumin; Disease Models, Animal; Humans; Nanoparticles; Nanotechnology; Neoplasms; Resveratrol; Stilbenes	2016
Targeting cancer stem-like cells using dietary-derived agents - Where are we now? Molecular nutrition & food research, 2016, Volume: 60, Issue:6 Topics: Animals; Anticarcinogenic Agents; Catechin; Cell Line, Tumor; Curcumin; Diet; Disease Models, Animal; Flavonoids; Humans; Isothiocyanates; Neoplasms; Neoplastic Stem Cells; Randomized Controlled Trials as Topic; Resveratrol; Stilbenes; Sulfoxides; Vitamin A	2016
Nutritional Epigenetics and the Prevention of Hepatocellular Carcinoma with Bioactive Food Constituents. Nutrition and cancer, 2016, Volume: 68, Issue:5 Topics: Animals; Butyric Acid; Carcinoma, Hepatocellular; Catechin; Cell Line, Tumor; Curcumin; Disease Models, Animal; DNA Methylation; Epigenesis, Genetic; Food; Humans; Isothiocyanates; Phytochemicals; Resveratrol; Stilbenes; Sulfoxides	2016
Therapeutic potential of green tea on risk factors for type 2 diabetes in obese adults - a review. Obesity reviews : an official journal of the International Association for the Study of Obesity, 2016, Volume: 17, Issue:12 Topics: Animals; Antioxidants; Body Composition; Catechin; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Inflammation; Insulin Resistance; Meta-Analysis as Topic; Obesity; Oxidative Stress; Phytotherapy; Randomized Controlled Trials as Topic; Risk Factors; Tea	2016
Anticancer Efficacy of Polyphenols and Their Combinations. Nutrients, 2016, Sep-09, Volume: 8, Issue:9 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Ascorbic Acid; Biological Availability; Catechin; Cell Line, Tumor; Cell Proliferation; Curcumin; Disease Models, Animal; Humans; Micronutrients; Neoplasms; Plant Extracts; Polyphenols; Quercetin; Resveratrol; Stilbenes; Tea	2016
[New perspectives on molecular and genic therapies in Down syndrome]. Medecine sciences : M/S, 2010, Volume: 26, Issue:4 Topics: Animals; Catechin; Chromosomes, Human, Pair 21; Disease Models, Animal; Down Syndrome; Droxidopa; Drug Delivery Systems; Fluoxetine; Forecasting; Gene Expression Regulation; Genetic Association Studies; Genetic Therapy; Hedgehog Proteins; Humans; Memantine; Mice; Mice, Transgenic; Models, Genetic; Neuronal Plasticity; Neurotransmitter Agents; Pentylenetetrazole; Phenotype; Signal Transduction	2010
Targeting cell signaling and apoptotic pathways by dietary agents: role in the prevention and treatment of cancer. Nutrition and cancer, 2011, Volume: 63, Issue:2 Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Catechin; Clinical Trials as Topic; Curcuma; Curcumin; Diet; Disease Models, Animal; Fruit; Genistein; Humans; Neoplasms; Resveratrol; Signal Transduction; Silymarin; Stilbenes; United States; Vegetables	2011
Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases. The Journal of nutritional biochemistry, 2004, Volume: 15, Issue:9 Topics: Alzheimer Disease; Animals; Antioxidants; Apoptosis; Catechin; Dietary Supplements; Disease Models, Animal; Flavonoids; Gene Expression Regulation; Humans; Iron Chelating Agents; Neuroprotective Agents; Parkinson Disease; Phenols; Polyphenols; Signal Transduction; Tea	2004
Neurodegeneration in autoimmune demyelination: recent mechanistic insights reveal novel therapeutic targets. Journal of neuroimmunology, 2007, Volume: 184, Issue:1-2 Topics: Acyl Coenzyme A; Animals; Catechin; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Humans; Multiple Sclerosis; Nerve Degeneration; Neuroprotective Agents; T-Lymphocytes; TNF-Related Apoptosis-Inducing Ligand	2007
Inhibition of carcinogenesis by tea constituents. Seminars in cancer biology, 2007, Volume: 17, Issue:5 Topics: Animals; Anticarcinogenic Agents; Catechin; Cell Transformation, Neoplastic; Disease Models, Animal; Flavonoids; Humans; Neoplasms; Phenols; Polyphenols; Tea	2007

Trials

4 trial(s) available for epigallocatechin gallate and Disease Models, Animal

Article	Year
Computational & theoretical chemistry, 2013, Feb-01, Volume: 1005 Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Amylose; Anaerobiosis; Animals; Anti-Bacterial Agents; Anura; Arginase; Arthritis, Rheumatoid; Asthma; Atmosphere; B-Lymphocytes; Basic Helix-Loop-Helix Transcription Factors; Bioelectric Energy Sources; Biofilms; Biofuels; Biomarkers; Biopolymers; Bioreactors; Brain; Brain Injuries, Traumatic; Breast Neoplasms; Calibration; Carbon Tetrachloride; Caspase 3; Catalysis; Catechin; Cations; Cattle; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Body; Cell Line, Tumor; Cell Plasticity; Chemical and Drug Induced Liver Injury; Chemistry Techniques, Synthetic; China; Chitosan; Chloride Channels; Chromatography, High Pressure Liquid; Chromosome Mapping; Cognition; Cognitive Dysfunction; Cohort Studies; Colitis, Ulcerative; Colloids; Coloring Agents; Congresses as Topic; Correlation of Data; Crystallization; Cyanoacrylates; Cyclohexane Monoterpenes; Cyprinidae; Cytochrome P-450 CYP1A1; Death, Sudden; Dent Disease; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Disease Progression; Disease Resistance; Disulfides; Drug Monitoring; Drug Stability; Ecotoxicology; Electricity; Electrodes; Endocytosis; Environmental Exposure; Environmental Monitoring; Enzyme Inhibitors; Epithelial-Mesenchymal Transition; Esophageal and Gastric Varices; Esters; Fagopyrum; Female; Ferrosoferric Oxide; Flame Retardants; Flavobacteriaceae; Flow Cytometry; Follow-Up Studies; Formoterol Fumarate; Fusarium; Garlic; Gastrointestinal Hemorrhage; Gene Expression; Genes, Plant; Genetic Markers; Glial Fibrillary Acidic Protein; Gliosis; Global Health; Glutathione Transferase; Glycine max; Gum Arabic; Hemostasis, Endoscopic; Hepatocytes; Hippocampus; Humans; Hydrogen-Ion Concentration; Illinois; Immunoglobulin G; Indoleamine-Pyrrole 2,3,-Dioxygenase; Infant, Newborn; Infant, Small for Gestational Age; Injections, Intraperitoneal; Interleukin-4; Iowa; Iron; Ki-67 Antigen; Kidney; Kinetics; Kynurenine; Lakes; Levofloxacin; Lipid Peroxidation; Lipids; Liver; Liver Cirrhosis, Experimental; Magnetic Fields; Magnetic Iron Oxide Nanoparticles; Male; Manure; Maze Learning; Memory, Short-Term; Metal Nanoparticles; Metals, Heavy; Methane; Mice; Mice, Inbred C57BL; Mice, Knockout; Michigan; Microalgae; Microbial Consortia; Mitochondria; Models, Animal; Models, Chemical; Models, Neurological; Molecular Structure; Molecular Weight; Mutation; Myeloid-Derived Suppressor Cells; NADPH Oxidase 2; Neoplasm Recurrence, Local; Neurites; Neurons; Neuroprotective Agents; NF-kappa B; NIH 3T3 Cells; Nitric Oxide Synthase Type II; Nitrogen; Ohio; Ointments; Ontario; Organelle Biogenesis; Organophosphates; Organophosphorus Compounds; Oxidative Stress; Palladium; Particle Size; Pectins; Phenotype; Phytotherapy; Piperidines; Placenta; Plant Diseases; Plant Extracts; Polymers; Polymorphism, Genetic; Polyphenols; Powders; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Protein Kinase Inhibitors; Protein Structure, Secondary; Proteins; Pyridines; Pyrimidines; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptors, Aryl Hydrocarbon; Receptors, Chemokine; Receptors, Formyl Peptide; Receptors, Lipoxin; Recovery of Function; Recurrence; Reference Standards; Reference Values; Reproducibility of Results; Respiratory Function Tests; Retrospective Studies; Risk; Sensitivity and Specificity; Sewage; Signal Transduction; Sodium Glutamate; Soil; Solanum tuberosum; Solubility; Solutions; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spermatozoa; STAT3 Transcription Factor; Sulfamethoxazole; Tea; Temperature; Thermodynamics; Thrombin; Treatment Outcome; Triazoles; United States; Viscosity; Waste Disposal, Fluid; Wastewater; Water; Water Pollutants, Chemical; Water Purification; White Matter; Wisconsin; X-Ray Diffraction; Zea mays	2013
A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome. Clinical nutrition (Edinburgh, Scotland), 2020, Volume: 39, Issue:2 Topics: Adult; Animals; Catechin; Cognition Disorders; Disease Models, Animal; Double-Blind Method; Female; Fragile X Syndrome; Humans; Male; Mice; Mice, Knockout; Middle Aged; Neuroprotective Agents; Treatment Outcome; Young Adult	2020
Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans. Molecular nutrition & food research, 2014, Volume: 58, Issue:2 Topics: Adolescent; Adult; Animals; Biomarkers; Catechin; Chromosomes, Human, Pair 16; Cognition; Disease Models, Animal; Double-Blind Method; Down Syndrome; Dyrk Kinases; Female; Gene Expression Regulation; Hippocampus; Humans; Male; Mice; Mice, Transgenic; Mosaicism; Phosphorylation; Pilot Projects; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Trisomy; Young Adult	2014
A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR. Cell death and differentiation, 2016, Volume: 23, Issue:8 Topics: Adolescent; Animals; Autophagy; Biomarkers; Catechin; Child; Cysteamine; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; Drug Therapy, Combination; Homozygote; Humans; Interleukin-8; Lung; Mice; Mice, Knockout; Mutation; Sputum; Tumor Necrosis Factor-alpha	2016

Other Studies

267 other study(ies) available for epigallocatechin gallate and Disease Models, Animal

Article	Year
Phenolic substances from Phagnalon rupestre protect against 2,4,6-trinitrochlorobenzene-induced contact hypersensitivity. Journal of natural products, 2011, May-27, Volume: 74, Issue:5 Topics: Animals; Cyclooxygenase 2 Inhibitors; Dermatitis, Contact; Disease Models, Animal; Dose-Response Relationship, Drug; Ear; Edema; Interleukin-1beta; Interleukin-2; Lipopolysaccharides; Macrophages; Mice; Phenols; Picryl Chloride; Skin; Tumor Necrosis Factor-alpha	2011
Potential of lichen secondary metabolites against Plasmodium liver stage parasites with FAS-II as the potential target. Journal of natural products, 2013, Jun-28, Volume: 76, Issue:6 Topics: Animals; Antimalarials; Disease Models, Animal; Enzyme Inhibitors; Fatty Acid Synthase, Type II; Hepatocytes; Humans; Lichens; Liver; Malaria; Molecular Structure; Mycobacterium tuberculosis; Plasmodium berghei; Plasmodium falciparum; Protozoan Proteins; Staphylococcus aureus; Zebrafish	2013
Nodulisporiviridins A-H, Bioactive Viridins from Nodulisporium sp. Journal of natural products, 2015, Jun-26, Volume: 78, Issue:6 Topics: Alzheimer Disease; Amyloid beta-Peptides; Androstenes; Animals; Bacteriocins; Catechin; China; Crystallography, X-Ray; Disease Models, Animal; Humans; Molecular Conformation; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Peptide Fragments; Xylariales	2015
Green tea extract inhibits the onset of periodontal destruction in rat experimental periodontitis. Journal of periodontal research, 2014, Volume: 49, Issue:5 Topics: Alveolar Bone Loss; Animals; Anti-Inflammatory Agents; Antibodies, Bacterial; Antigen-Antibody Complex; Camellia sinensis; Connective Tissue; Disease Models, Animal; Epithelial Attachment; Escherichia coli; Immunization; Immunoglobulin G; Lipopolysaccharides; Male; Osteoclasts; Periodontal Attachment Loss; Periodontitis; Phenols; Phytotherapy; Plant Extracts; RANK Ligand; Rats; Rats, Inbred Lew	2014
Epigallocatechin gallate (EGCG) attenuates staphylococcal alpha-hemolysin (Hla)-induced NLRP3 inflammasome activation via ROS-MAPK pathways and EGCG-Hla interactions. International immunopharmacology, 2021, Volume: 100 Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Bacterial Proteins; Catechin; Disease Models, Animal; Hemolysin Proteins; Hemolysis; Humans; Inflammasomes; Male; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Reactive Oxygen Species; Signal Transduction; Staphylococcal Infections; Staphylococcus aureus; THP-1 Cells	2021
Effect of (-)-Epigallocatechin Gallate on Activation of JAK/STAT Signaling Pathway by Staphylococcal Enterotoxin A. Toxins, 2021, 08-29, Volume: 13, Issue:9 Topics: Animals; Catechin; Cells, Cultured; Disease Models, Animal; Enterotoxins; Gene Expression Regulation, Bacterial; Humans; Janus Kinases; Mice; Signal Transduction; Spleen; Staphylococcus aureus; STAT3 Transcription Factor	2021
Epigallocatechin gallate (EGCG) attenuates myocardial hypertrophy and fibrosis induced by transverse aortic constriction via inhibiting the Akt/mTOR pathway. Pharmaceutical biology, 2021, Volume: 59, Issue:1 Topics: Animals; Cardiomegaly; Cardiotonic Agents; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Male; Mice; Mice, Inbred C57BL; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases	2021
EGCG protects against myocardial I/RI by regulating lncRNA Gm4419-mediated epigenetic silencing of the DUSP5/ERK1/2 axis. Toxicology and applied pharmacology, 2021, 12-15, Volume: 433 Topics: Animals; Autophagy; Catechin; Cells, Cultured; Disease Models, Animal; Dual-Specificity Phosphatases; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Gene Silencing; Hydrogen Peroxide; Male; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardial Reperfusion Injury; Myocytes, Cardiac; RNA, Long Noncoding; Signal Transduction	2021
EGCG prevents pressure overload‑induced myocardial remodeling by downregulating overexpression of HDAC5 in mice. International journal of molecular medicine, 2022, Volume: 49, Issue:1 Topics: Acetylation; Animals; Atrial Natriuretic Factor; Atrial Remodeling; Catechin; Constriction; Disease Models, Animal; Electrocardiography; Heart Failure; Histone Deacetylases; Histones; Lysine; Male; MEF2 Transcription Factors; Natriuretic Peptide, Brain; Survival Rate; Ventricular Remodeling	2022
Epigallocatechin Gallate (EGCG), a Green Tea Polyphenol, Reduces Coronavirus Replication in a Mouse Model. Viruses, 2021, 12-17, Volume: 13, Issue:12 Topics: Animals; Antiviral Agents; Catechin; Cell Line; Coronavirus Infections; Coronavirus OC43, Human; Disease Models, Animal; Humans; Mice; Polyphenols; Tea; Virus Replication	2021
Treg/Th17 Ratio Regulation May Play an Important Role in Epigallocatechin-3-Gallate-Mediated Attenuation of Increased Afterload-Induced Cardiac Hypertrophy. Journal of cardiovascular pharmacology, 2022, 05-01, Volume: 79, Issue:5 Topics: Animals; Cardiomegaly; Catechin; Disease Models, Animal; Eosine Yellowish-(YS); Hematoxylin; Male; Mice; Mice, Inbred C57BL; T-Lymphocytes, Regulatory; Th17 Cells; Wheat Germ Agglutinins	2022
Analysis of the role and mechanism of EGCG in septic cardiomyopathy based on network pharmacology. PeerJ, 2022, Volume: 10 Topics: Animals; Cardiomyopathies; Disease Models, Animal; Interleukin-6; Lipopolysaccharides; Mice; Molecular Docking Simulation; Network Pharmacology; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A	2022
Epigallocatechin-3-gallate exerts cardioprotective effects related to energy metabolism in pressure overload-induced cardiac dysfunction. Archives of biochemistry and biophysics, 2022, 07-15, Volume: 723 Topics: Animals; Cardiomegaly; Catechin; Disease Models, Animal; Energy Metabolism; Heart Failure; Myocardium; Rats; Reproducibility of Results	2022
Oral antimicrobial peptide-EGCG nanomedicines for synergistic treatment of ulcerative colitis. Journal of controlled release : official journal of the Controlled Release Society, 2022, Volume: 347 Topics: Animals; Antimicrobial Peptides; Catechin; Colitis; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Inflammation; Lipopolysaccharides; Mice; Nanomedicine; RAW 264.7 Cells	2022
Tea polyphenol epigallocatechin-3-gallate inhibits cell proliferation in a patient-derived triple-negative breast cancer xenograft mouse model via inhibition of proline-dehydrogenase-induced effects. Journal of food and drug analysis, 2021, 03-15, Volume: 29, Issue:1 Topics: Animals; Catechin; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Heterografts; Humans; Mice; Polyphenols; Proline; Proline Oxidase; Tea; Triple Negative Breast Neoplasms	2021
Effect of Epigallocatechin-3-gallate on Stress-Induced Depression in a Mouse Model: Role of Interleukin-1β and Brain-Derived Neurotrophic Factor. Neurochemical research, 2022, Volume: 47, Issue:11 Topics: Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antioxidants; Brain-Derived Neurotrophic Factor; Catechin; Clomipramine; Depression; Disease Models, Animal; Hippocampus; Interleukin-1beta; Mice; RNA, Messenger; Stress, Psychological; Tea	2022
Epigallocatechin-3-gallate alleviates galactose-induced aging impairment Food & function, 2022, Oct-31, Volume: 13, Issue:21 Topics: Aging; Animals; Brain; Catechin; Disease Models, Animal; Galactose; Hypothalamo-Hypophyseal System; Mice; Pituitary-Adrenal System; Tea	2022
Study on the preparation of EGCG-γ-Cyclodextrin inclusion complex and its drug-excipient combined therapeutic effects on the treatment of DSS-induced acute ulcerative colitis in mice. International journal of pharmaceutics, 2023, Jan-05, Volume: 630 Topics: Animals; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Excipients; gamma-Cyclodextrins; Interleukin-6; Mice; Mice, Inbred C57BL; Tumor Necrosis Factor-alpha	2023
Synergistic effects of L-theanine and epigallocatechin gallate in alleviating ovalbumin allergy by regulating intestinal immunity through inhibition of mast cell degranulation. Food & function, 2023, Feb-21, Volume: 14, Issue:4 Topics: Animals; Cell Degranulation; Cytokines; Disease Models, Animal; Female; Hypersensitivity; Interleukin-13; Interleukin-4; Mast Cells; Mice; Mice, Inbred BALB C; Ovalbumin; Phosphatidylinositol 3-Kinases	2023
Effect of Alleviating Fibrosis with EGCG-Modified Bone Graft in Murine Model Depended on Less Accumulation of Inflammatory Macrophage. BioMed research international, 2023, Volume: 2023 Topics: Animals; Bone Regeneration; Capsules; Catechin; Disease Models, Animal; Durapatite; Macrophages; Mice; Osteogenesis	2023
EGCG attenuated acute myocardial infarction by inhibiting ferroptosis via miR-450b-5p/ACSL4 axis. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2023, Volume: 119 Topics: Animals; Catechin; Disease Models, Animal; Mice; MicroRNAs; Myocardial Infarction; Myocardial Ischemia	2023
Effect of a Flavonoid Combination of Apigenin and Epigallocatechin-3-Gallate on Alleviating Intestinal Inflammation in Experimental Colitis Models. International journal of molecular sciences, 2023, Nov-07, Volume: 24, Issue:22 Topics: Animals; Apigenin; Caco-2 Cells; Colitis; Cytokines; Dextran Sulfate; Disease Models, Animal; Flavonoids; Humans; Inflammation; Inflammatory Bowel Diseases	2023
Cerebral protection of epigallocatechin gallate (EGCG) via preservation of mitochondrial function and ERK inhibition in a rat resuscitation model. Drug design, development and therapy, 2019, Volume: 13 Topics: Animals; Cardiopulmonary Resuscitation; Catechin; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Heart Arrest; Male; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Phosphorylation; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley	2019
ERK1/2-HNF4α axis is involved in epigallocatechin-3-gallate inhibition of HBV replication. Acta pharmacologica Sinica, 2020, Volume: 41, Issue:2 Topics: Animals; Antiviral Agents; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation, Viral; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Hepatocyte Nuclear Factor 4; Humans; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Virus Replication	2020
Green Tea Polyphenol (-)-Epigallocatechin Gallate (EGCG) Attenuates Neuroinflammation in Palmitic Acid-Stimulated BV-2 Microglia and High-Fat Diet-Induced Obese Mice. International journal of molecular sciences, 2019, Oct-13, Volume: 20, Issue:20 Topics: Animals; Anti-Obesity Agents; Catechin; Cell Line; Diet, High-Fat; Disease Models, Animal; Hypothalamus; Inflammation; Interleukin-1beta; Interleukin-6; Janus Kinase 2; Lipid Metabolism; Mice; Mice, Inbred C57BL; Mice, Obese; Microglia; Obesity; Palmitic Acid; Polyphenols; STAT3 Transcription Factor; Tea; Tumor Necrosis Factor-alpha	2019
Epigallocatechin 3-gallate attenuates arthritis by regulating Nrf2, HO-1, and cytokine levels in an experimental arthritis model. Biotechnology and applied biochemistry, 2020, Volume: 67, Issue:3 Topics: Animals; Arthritis, Experimental; Catechin; Collagen Type II; Cytokines; Disease Models, Animal; Female; Heme Oxygenase (Decyclizing); NF-E2-Related Factor 2; Rats; Rats, Wistar	2020
A mouse model of subacute liver failure with ascites induced by step-wise increased doses of (-)-epigallocatechin-3-gallate. Scientific reports, 2019, 12-02, Volume: 9, Issue:1 Topics: Acute Disease; Animals; Antioxidants; Apoptosis; Aquaporin 2; Ascites; Catechin; Disease Models, Animal; Kidney; Liver; Liver Failure; Male; Membrane Transport Proteins; Mice; Urea Transporters	2019
MicroRNA-384-5p/Beclin-1 As Potential Indicators For Epigallocatechin Gallate Against Cardiomyocytes Ischemia Reperfusion Injury By Inhibiting Autophagy Via PI3K/Akt Pathway. Drug design, development and therapy, 2019, Volume: 13 Topics: Animals; Autophagy; Beclin-1; Catechin; Cell Survival; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; HEK293 Cells; Humans; MicroRNAs; Molecular Structure; Myocardial Reperfusion Injury; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Structure-Activity Relationship	2019
Protective Effect of (-)Epigallocatechin-3-gallate on Rotenone-Induced Parkinsonism-like Symptoms in Rats. Neurotoxicity research, 2020, Volume: 37, Issue:3 Topics: Animals; Apoptosis; Behavior, Animal; Catechin; Corpus Striatum; Disease Models, Animal; Encephalitis; Inflammation Mediators; Male; Neuroprotective Agents; Parkinsonian Disorders; Rats, Wistar; Rotenone	2020
Protective Effect of Epigallocatechin Gallate in Ischemia-Reperfusion Injury of Rat Skeletal Muscle. The Journal of surgical research, 2020, Volume: 247 Topics: Animals; Antioxidants; Catechin; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Kidney; Liver; Male; Muscle, Skeletal; Oxidative Stress; Rats; Reactive Oxygen Species; Reperfusion Injury	2020
Green tea polyphenols and epigallocatechin-3-gallate protect against perfluorodecanoic acid induced liver damage and inflammation in mice by inhibiting NLRP3 inflammasome activation. Food research international (Ottawa, Ont.), 2020, Volume: 127 Topics: Animals; Antioxidants; Catechin; Decanoic Acids; Disease Models, Animal; Fluorocarbons; Inflammasomes; Inflammation; Liver Diseases; Male; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Polyphenols; Tea	2020
(-)-Epigallocatechin-3-gallate provides neuroprotection via AMPK activation against traumatic brain injury in a mouse model. Naunyn-Schmiedeberg's archives of pharmacology, 2020, Volume: 393, Issue:11 Topics: AMP-Activated Protein Kinases; Animals; Behavior, Animal; Brain Injuries, Traumatic; Catechin; Cerebral Cortex; Cognition; Cytokines; Disease Models, Animal; Enzyme Activation; Inflammation Mediators; Male; Mice, Inbred C57BL; Mice, Knockout; Morris Water Maze Test; Motor Activity; Neuroprotective Agents; NF-kappa B; Oxidative Stress; Phosphorylation; Rotarod Performance Test; Signal Transduction	2020
EGCG ameliorates neuronal and behavioral defects by remodeling gut microbiota and TotM expression in Drosophila models of Parkinson's disease. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2020, Volume: 34, Issue:4 Topics: Animals; Behavior, Animal; Catechin; Disease Models, Animal; Drosophila melanogaster; Drosophila Proteins; Female; Gastrointestinal Microbiome; Heat-Shock Proteins; Male; Mitochondria; Neuroprotective Agents; Parkinson Disease	2020
Epigallocatechin-3-gallate Alleviates Cognitive Deficits in APP/PS1 Mice. Current medical science, 2020, Volume: 40, Issue:1 Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Catechin; Cognitive Dysfunction; Cytokines; Disease Models, Animal; Gene Expression Regulation; Humans; Mice; Mice, Transgenic; Mutation; Neuroprotective Agents; Presenilin-1; Treatment Outcome	2020
(-)-Epigallocatechin-3-gallate (EGCG) attenuates salt-induced hypertension and renal injury in Dahl salt-sensitive rats. Scientific reports, 2020, 03-16, Volume: 10, Issue:1 Topics: Acute Kidney Injury; Administration, Oral; Animals; Apoptosis; Catechin; Cells, Cultured; Disease Models, Animal; Fibroblasts; Hypertension; Malondialdehyde; Phytotherapy; Rats; Rats, Inbred Dahl; Receptors, Laminin; Sodium Chloride, Dietary	2020
Epigallocatechin gallate alleviates neuronal cell damage against focal cerebral ischemia in rats. The Journal of veterinary medical science, 2020, May-20, Volume: 82, Issue:5 Topics: Animals; Apoptosis; Brain Ischemia; Caspase 3; Catechin; Cerebral Infarction; Disease Models, Animal; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Poly(ADP-ribose) Polymerases; Rats, Sprague-Dawley	2020
Efficacy of Topical Treatment with (-)-Epigallocatechin Gallate, A Green Tea Catechin, in Mice with Cutaneous Leishmaniasis. Molecules (Basel, Switzerland), 2020, Apr-10, Volume: 25, Issue:7 Topics: Animals; Antiprotozoal Agents; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Leishmania mexicana; Leishmaniasis, Cutaneous; Mice; Parasitic Sensitivity Tests; Tea	2020
Prefrontal-hippocampal functional connectivity encodes recognition memory and is impaired in intellectual disability. Proceedings of the National Academy of Sciences of the United States of America, 2020, 05-26, Volume: 117, Issue:21 Topics: Animals; Catechin; Disease Models, Animal; Down Syndrome; Executive Function; Female; Hippocampus; Male; Mice; Mice, Inbred C57BL; Nerve Net; Neuroprotective Agents; Prefrontal Cortex; Recognition, Psychology	2020
Theaphenon E prevents fatty liver disease and increases CD4+ T cell survival in mice fed a high-fat diet. Clinical nutrition (Edinburgh, Scotland), 2021, Volume: 40, Issue:1 Topics: Animals; Apoptosis; Catechin; CD4-Positive T-Lymphocytes; Cell Proliferation; Diet, Fat-Restricted; Diet, High-Fat; Disease Models, Animal; Fatty Acids; Hepatocytes; Humans; Linoleic Acid; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity	2021
Epigallocatechin-3-gallate protects immunity and liver drug-metabolism function in mice loaded with restraint stress. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 129 Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Biotransformation; Catechin; Cytochrome P-450 Enzyme System; Cytokines; Disease Models, Animal; Female; Immunoglobulin A, Secretory; Immunologic Factors; Inflammation Mediators; Isoenzymes; Liver; Male; Mice, Inbred ICR; Oxidative Stress; Restraint, Physical; Stress, Physiological; Stress, Psychological; T-Lymphocyte Subsets	2020
Evaluation of the therapeutic potential of Epigallocatechin-3-gallate (EGCG) via oral gavage in young adult Down syndrome mice. Scientific reports, 2020, 06-26, Volume: 10, Issue:1 Topics: Administration, Oral; Animals; Body Weight; Cancellous Bone; Catechin; Disease Models, Animal; Down Syndrome; Femur; Maze Learning; Mice; Treatment Outcome; X-Ray Microtomography	2020
Long-acting mucoadhesive thermogels for improving topical treatments of dry eye disease. Materials science & engineering. C, Materials for biological applications, 2020, Volume: 115 Topics: Acrylic Resins; Administration, Topical; Animals; Apoptosis; Catechin; Cell Line; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Dry Eye Syndromes; Female; Gelatin; Humans; Lectins; Ophthalmic Solutions; Oxidative Stress; Rabbits	2020
Brain-targeted co-delivery of β-amyloid converting enzyme 1 shRNA and epigallocatechin-3-gallate by multifunctional nanocarriers for Alzheimer's disease treatment. IUBMB life, 2020, Volume: 72, Issue:8 Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Blood-Brain Barrier; Brain; Catechin; Disease Models, Animal; Humans; Mice; Mice, Transgenic; RNA, Small Interfering	2020
Effects of EGCG on depression-related behavior and serotonin concentration in a rat model of chronic unpredictable mild stress. Food & function, 2020, Oct-21, Volume: 11, Issue:10 Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain; Catechin; Colon; Depression; Disease Models, Animal; Hippocampus; Male; Open Field Test; Rats; Rats, Wistar; Serotonin; Stress, Psychological; Swimming	2020
Re-establishment of the epigenetic state and rescue of kinome deregulation in Ts65Dn mice upon treatment with green tea extract and environmental enrichment. Scientific reports, 2020, 09-29, Volume: 10, Issue:1 Topics: Animals; Camellia sinensis; Catechin; Chromatography, Liquid; Cognition; Disease Models, Animal; Down Syndrome; Epigenesis, Genetic; Hippocampus; Mice; Mice, Transgenic; Phosphorylation; Plant Extracts; Protein Interaction Maps; Proteomics; Tandem Mass Spectrometry	2020
Epigallocatechin gallate induces chemopreventive effects on rats with diethylnitrosamine‑induced liver cancer via inhibition of cell division cycle 25A. Molecular medicine reports, 2020, Volume: 22, Issue:5 Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Catechin; cdc25 Phosphatases; Cell Cycle; Cell Proliferation; Cell Survival; Diethylnitrosamine; Disease Models, Animal; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Male; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Tea; Transfection; Tumor Burden	2020
Epigallocatechin-3-Gallate Reduces Visceral Adiposity Partly through the Regulation of Beclin1-Dependent Autophagy in White Adipose Tissues. Nutrients, 2020, Oct-08, Volume: 12, Issue:10 Topics: Adipose Tissue, White; Adiposity; Animals; Autophagy; Beclin-1; Catechin; Diet, High-Fat; Disease Models, Animal; Gene Expression Regulation, Developmental; Intra-Abdominal Fat; Male; Mice; Mice, Inbred C57BL; Obesity	2020
Epigallocatechin-3-gallate reduces liver and immune system damage in Acinetobacter baumannii-loaded mice with restraint stress. International immunopharmacology, 2021, Volume: 92 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Antioxidants; Catechin; Disease Models, Animal; Female; Immune System; Inflammation; Liver Diseases; Male; Mice; Mice, Inbred ICR; Oxidative Stress	2021
Modulators of Neuroinflammation Have a Beneficial Effect in a Lafora Disease Mouse Model. Molecular neurobiology, 2021, Volume: 58, Issue:6 Topics: Animals; Biomarkers; Brain; Catechin; Disease Models, Animal; Gliosis; Glucans; Hippocampus; Inclusion Bodies; Inflammation; Lafora Disease; Mice, Inbred C57BL; Mice, Knockout; Microglia; Motor Activity; Nerve Degeneration; Neurons; Phenotype; Propranolol; Ubiquitin-Protein Ligases	2021
Epigallocatechin Gallate Ameliorates the Effects of Prenatal Alcohol Exposure in a Fetal Alcohol Spectrum Disorder-Like Mouse Model. International journal of molecular sciences, 2021, Jan-13, Volume: 22, Issue:2 Topics: Animals; Astrocytes; Biomarkers; Catechin; Cell Differentiation; Disease Models, Animal; Doublecortin Protein; Ethanol; Female; Fetal Alcohol Spectrum Disorders; Immunohistochemistry; Male; Maternal Exposure; Mice; Neurogenesis; Neurons; Oxidative Stress; Placenta; Pregnancy; Prenatal Exposure Delayed Effects	2021
Epigallocatechin-3-gallate prevents inflammation and diabetes -Induced glucose tolerance through inhibition of NLRP3 inflammasome activation. International immunopharmacology, 2021, Volume: 93 Topics: Animals; Anti-Inflammatory Agents; Bone Marrow; Catechin; Cells, Cultured; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Glucose Tolerance Test; Humans; Inflammasomes; Inflammation; Macrophages; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Pyroptosis	2021
Green tea extracts containing epigallocatechin-3-gallate modulate facial development in Down syndrome. Scientific reports, 2021, 02-25, Volume: 11, Issue:1 Topics: Adolescent; Animals; Catechin; Child; Child, Preschool; Dietary Supplements; Disease Models, Animal; Down Syndrome; Face; Female; Humans; Infant; Male; Mice; Plant Extracts; Tea	2021
Epigallocatechin-3-Gallate Dampens Non-Alcoholic Fatty Liver by Modulating Liver Function, Lipid Profile and Macrophage Polarization. Nutrients, 2021, Feb-11, Volume: 13, Issue:2 Topics: Adipose Tissue; Animals; Body Weight; Catechin; Cholesterol; Diet, High-Fat; Disease Models, Animal; Lipids; Liver; Macrophages; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Organ Size	2021
Identification of regulated proteins by epigallocatechin gallate treatment in an ischemic cerebral cortex animal model: a proteomics approach. The Journal of veterinary medical science, 2021, Jun-09, Volume: 83, Issue:6 Topics: Animals; Catechin; Cerebral Cortex; Disease Models, Animal; Infarction, Middle Cerebral Artery; Proteomics; Rats; Rats, Sprague-Dawley; Rodent Diseases	2021
Epigallocatechin-3-Gallate Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease via Inhibition of Apoptosis and Promotion of Autophagy through the ROS/MAPK Signaling Pathway. Oxidative medicine and cellular longevity, 2021, Volume: 2021 Topics: Animals; Apoptosis; Autophagy; Catechin; Diet, High-Fat; Disease Models, Animal; Disease Progression; Humans; Male; Mice; Mitogen-Activated Protein Kinases; Non-alcoholic Fatty Liver Disease; Signal Transduction	2021
Natural antioxidants enhance the power of physical and mental activities versus risk factors inducing progression of Alzheimer's disease in rats. International immunopharmacology, 2021, Volume: 96 Topics: Alzheimer Disease; Animals; Antioxidants; Ascorbic Acid; Catechin; Disease Models, Animal; Disease Progression; Male; Mental Health; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Risk Factors; Selenium; Vitamin E	2021
Epigallocatechin-3-gallate attenuates acute pancreatitis induced lung injury by targeting mitochondrial reactive oxygen species triggered NLRP3 inflammasome activation. Food & function, 2021, Jun-21, Volume: 12, Issue:12 Topics: Acute Lung Injury; Animals; Antioxidants; Catechin; Disease Models, Animal; DNA, Mitochondrial; Inflammasomes; Inflammation; Lung; Lung Injury; Male; Mice; Mitochondria; NLR Family, Pyrin Domain-Containing 3 Protein; Pancreatitis; Reactive Oxygen Species; Tea	2021
[Constructing Brain Aβ-Targeting Nanoparticles Loaded with EGCG for Treating Alzheimer's Disease in Mice]. Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2021, Volume: 52, Issue:4 Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Catechin; Disease Models, Animal; Hippocampus; Mice; Mice, Inbred ICR; Nanoparticles; Oligopeptides	2021
Epigallocatechin gallate upregulates NRF2 to prevent diabetic nephropathy via disabling KEAP1. Free radical biology & medicine, 2017, Volume: 108 Topics: Animals; Catechin; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Inflammation; Kelch-Like ECH-Associated Protein 1; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-E2-Related Factor 2; Oxidative Stress; RNA, Small Interfering; Signal Transduction; Up-Regulation	2017
Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes. Physiology & behavior, 2017, Aug-01, Volume: 177 Topics: Administration, Oral; Animals; Brain; Catechin; Cognition; Disease Models, Animal; Down Syndrome; Dyrk Kinases; Femur; Male; Maze Learning; Mice, Inbred C3H; Mice, Transgenic; Motor Activity; Phenotype; Protease Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Random Allocation; Recognition, Psychology; Treatment Failure	2017
PDE3 inhibitor and EGCG combination treatment suppress cancer stem cell properties in pancreatic ductal adenocarcinoma. Scientific reports, 2017, 05-15, Volume: 7, Issue:1 Topics: Animals; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Catechin; Cell Line, Tumor; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Disease Models, Animal; Drug Synergism; Fluorescent Antibody Technique; Gene Expression; Humans; Mice; Neoplastic Stem Cells; Phosphodiesterase 3 Inhibitors; Xenograft Model Antitumor Assays	2017
(-)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer's disease. Neuroreport, 2017, Jul-05, Volume: 28, Issue:10 Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Catechin; Disease Models, Animal; Disks Large Homolog 4 Protein; Frontal Lobe; Hippocampus; Maze Learning; Memory Disorders; Mice; Motor Activity; Neuroprotective Agents; Nootropic Agents; Peptide Fragments; Phosphorylation; Random Allocation; Spatial Memory; Synaptophysin; tau Proteins	2017
Anti-inflammatory effect of epigallocatechin gallate in a mouse model of ovalbumin-induced allergic rhinitis. International immunopharmacology, 2017, Volume: 49 Topics: Allergens; Animals; Anti-Inflammatory Agents; Catechin; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Female; Histamine; Humans; Immunoglobulin E; Inflammation Mediators; Mice; Mice, Inbred BALB C; Ovalbumin; Rhinitis, Allergic; Sneezing; Tea	2017
Epigallocatechin-3-gallate and related phenol compounds redirect the amyloidogenic aggregation pathway of ataxin-3 towards non-toxic aggregates and prevent toxicity in neural cells and Caenorhabditis elegans animal model. Human molecular genetics, 2017, 09-01, Volume: 26, Issue:17 Topics: Amyloid; Amyloidogenic Proteins; Animals; Ataxin-3; Caenorhabditis elegans; Catechin; Disease Models, Animal; Humans; Hydrogen Bonding; Molecular Docking Simulation; Nerve Tissue Proteins; Neurodegenerative Diseases; Neurons; Nuclear Proteins; Peptides; Phenols	2017
Green tea polyphenols ameliorate non-alcoholic fatty liver disease through upregulating AMPK activation in high fat fed Zucker fatty rats. World journal of gastroenterology, 2017, Jun-07, Volume: 23, Issue:21 Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Antioxidants; Catechin; Diet, High-Fat; Disease Models, Animal; Humans; Lipid Metabolism; Lipogenesis; Liver; Liver Function Tests; Male; Non-alcoholic Fatty Liver Disease; Phosphorylation; Polyphenols; Rats; Rats, Zucker; Signal Transduction; Sterol Regulatory Element Binding Protein 1; Tea; Transcriptional Activation; Triglycerides; Up-Regulation; Weight Gain	2017
Identification of Circulating miR-125b as a Potential Biomarker of Alzheimer's Disease in APP/PS1 Transgenic Mouse. Journal of Alzheimer's disease : JAD, 2017, Volume: 59, Issue:4 Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Biomarkers; Catechin; Cell Line, Tumor; Cognition Disorders; Disease Models, Animal; Gene Expression Regulation; Humans; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; MicroRNAs; Mutation; Neuroblastoma; Presenilin-1; Protease Inhibitors; RNA, Messenger	2017
Possible role of antioxidative capacity of (-)-epigallocatechin-3-gallate treatment in morphological and neurobehavioral recovery after sciatic nerve crush injury. Journal of neurosurgery. Spine, 2017, Volume: 27, Issue:5 Topics: Animals; Antioxidants; Axons; Catechin; Crush Injuries; Disease Models, Animal; Hyperalgesia; Male; Motor Activity; Nerve Regeneration; Neuroprotective Agents; Oxidative Stress; Peripheral Nerve Injuries; Random Allocation; Rats, Wistar; Recovery of Function; RNA, Messenger; Sciatic Nerve; Sciatic Neuropathy; Spinal Cord	2017
(-)-Epigallocatechin-3-gallate and atorvastatin treatment down-regulates liver fibrosis-related genes in non-alcoholic fatty liver disease. Clinical and experimental pharmacology & physiology, 2017, Volume: 44, Issue:12 Topics: Animals; Atorvastatin; Catechin; Disease Models, Animal; Down-Regulation; Fibrillar Collagens; Gene Expression; Humans; Liver Cirrhosis; Male; Mice, Inbred C57BL; Multigene Family; Non-alcoholic Fatty Liver Disease	2017
Combinatorial bioactive botanicals re-sensitize tamoxifen treatment in ER-negative breast cancer via epigenetic reactivation of ERα expression. Scientific reports, 2017, 08-24, Volume: 7, Issue:1 Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Catechin; Cell Line, Tumor; Disease Models, Animal; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Epigenesis, Genetic; Estrogen Receptor alpha; Heterografts; Humans; Isothiocyanates; Mice; Neoplasm Transplantation; Phytochemicals; Sulfoxides; Tamoxifen; Treatment Outcome	2017
Green tea supplementation produces better neuroprotective effects than red and black tea in Alzheimer-like rat model. Food research international (Ottawa, Ont.), 2017, Volume: 100, Issue:Pt 1 Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Behavior, Animal; Body Weight; Catechin; Disease Models, Animal; Hippocampus; Male; Memory; Neuroprotective Agents; Oxidative Stress; Rats; Rats, Wistar; Tea	2017
Effects of green tea epigallocatechin-3-gallate on the proteolipid protein and oligodendrocyte transcription factor 1 messenger RNA gene expression in a mouse model of multiple sclerosis. Folia neuropathologica, 2017, Volume: 55, Issue:3 Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Brain; Catechin; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Mice, Inbred C57BL; Multiple Sclerosis; Oligodendroglia; RNA, Messenger; Tea	2017
Anti-oxidants correct disturbance of redox enzymes in the hearts of rat fetuses with congenital diaphragmatic hernia. Pediatric surgery international, 2018, Volume: 34, Issue:3 Topics: Acetophenones; Animals; Antioxidants; Catalase; Catechin; Disease Models, Animal; Female; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Hernias, Diaphragmatic, Congenital; Hydrogen Peroxide; Myocardium; NADPH Oxidase 1; NADPH Oxidase 2; NADPH Oxidase 4; Pregnancy; Rats; Rats, Sprague-Dawley; RNA, Messenger; Superoxide Dismutase	2018
Epigallocatechin-3-gallate inhibits inflammation and epithelial‑mesenchymal transition through the PI3K/AKT pathway via upregulation of PTEN in asthma. International journal of molecular medicine, 2018, Volume: 41, Issue:2 Topics: Airway Remodeling; Animals; Asthma; Catechin; Disease Models, Animal; Epithelial-Mesenchymal Transition; Humans; Inflammation; Mice; Oncogene Protein v-akt; Ovalbumin; Phosphatidylinositol 3-Kinases; PTEN Phosphohydrolase; Signal Transduction; Tea	2018
EGCG-mediated Protection of the Membrane Disruption and Cytotoxicity Caused by the 'Active Oligomer' of α-Synuclein. Scientific reports, 2017, 12-20, Volume: 7, Issue:1 Topics: alpha-Synuclein; Amyloid; Animals; Catechin; Cell Membrane; Disease Models, Animal; Drosophila melanogaster; Electrophoresis, Polyacrylamide Gel; Microscopy, Electron, Transmission; Parkinson Disease	2017
Effects of (-)-epigallocatechin-3-gallate on EGFR- or Fusion Gene-driven Lung Cancer Cells. Acta medica Okayama, 2017, Volume: 71, Issue:6 Topics: Anaplastic Lymphoma Kinase; Animals; Blood Proteins; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Catechin; Cell Line, Tumor; Crizotinib; Disease Models, Animal; ErbB Receptors; Female; Gene Rearrangement; Heterografts; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Mutation; Oncogene Proteins, Fusion; Polyphenols; Protein S; Protein-Tyrosine Kinases; Pyrazoles; Pyridines; Receptor Protein-Tyrosine Kinases; Tea	2017
Structural shift of gut microbiota during chemo-preventive effects of epigallocatechin gallate on colorectal carcinogenesis in mice. World journal of gastroenterology, 2017, Dec-14, Volume: 23, Issue:46 Topics: Aberrant Crypt Foci; Animals; Anticarcinogenic Agents; Azoxymethane; Carcinogenesis; Carcinogens; Catechin; Colon; Colorectal Neoplasms; Dextran Sulfate; Disease Models, Animal; Female; Gastrointestinal Microbiome; Humans; Mice; Rectum; RNA, Ribosomal, 16S	2017
(-)-Epigallocatechin-3-gallate modulates peripheral immunity in the MPTP-induced mouse model of Parkinson's disease. Molecular medicine reports, 2018, Volume: 17, Issue:4 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Catechin; Disease Models, Animal; Dopaminergic Neurons; Immunomodulation; Male; Mice; Neuroprotective Agents; Parkinson Disease; T-Lymphocyte Subsets; Tyrosine 3-Monooxygenase	2018
EGCG Maintains Th1/Th2 Balance and Mitigates Ulcerative Colitis Induced by Dextran Sulfate Sodium through TLR4/MyD88/NF- Canadian journal of gastroenterology & hepatology, 2017, Volume: 2017 Topics: Animals; Catechin; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Intestinal Mucosa; Intestines; Male; Myeloid Differentiation Factor 88; Neuroprotective Agents; NF-kappa B; Rats; Rats, Sprague-Dawley; Signal Transduction; Spleen; Th1-Th2 Balance; Toll-Like Receptor 4	2017
Ameliorative Effect of Epigallocatechin Gallate on Cardiac Hypertrophy and Fibrosis in Aged Rats. Journal of cardiovascular pharmacology, 2018, Volume: 71, Issue:2 Topics: Age Factors; Aging; Animals; Antioxidants; Apoptosis; Cardiomyopathies; Catechin; Disease Models, Animal; Fibrosis; Hypertrophy, Left Ventricular; Lipids; Myocytes, Cardiac; Oxidative Stress; Rats, Wistar; Reactive Oxygen Species; Signal Transduction; Ventricular Function, Left; Ventricular Remodeling	2018
SOX2OT variant 7 contributes to the synergistic interaction between EGCG and Doxorubicin to kill osteosarcoma via autophagy and stemness inhibition. Journal of experimental & clinical cancer research : CR, 2018, Feb-23, Volume: 37, Issue:1 Topics: Animals; Apoptosis; Autophagy; Biomarkers; Bone Neoplasms; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Self Renewal; Disease Models, Animal; Doxorubicin; Gene Expression; Humans; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Mice; Neoplastic Stem Cells; Osteosarcoma; Receptor, Notch3; RNA, Long Noncoding; Xenograft Model Antitumor Assays	2018
Epigallocatechin-3-gallate improves cardiac hypertrophy and short-term memory deficits in a Williams-Beuren syndrome mouse model. PloS one, 2018, Volume: 13, Issue:3 Topics: Animals; Cardiomegaly; Catechin; Disease Models, Animal; Memory Disorders; Memory, Short-Term; Mice; Mice, Mutant Strains; Williams Syndrome	2018
Epigallocatechin-3-gallate alleviates bladder overactivity in a rat model with metabolic syndrome and ovarian hormone deficiency through mitochondria apoptosis pathways. Scientific reports, 2018, 03-29, Volume: 8, Issue:1 Topics: Animals; Apoptosis; Biomarkers; Catechin; Diet, Carbohydrate Loading; Diet, High-Fat; Disease Models, Animal; Female; Metabolic Syndrome; Mitochondria; Ovariectomy; Oxidative Stress; Plant Extracts; Primary Ovarian Insufficiency; Rats; Rats, Sprague-Dawley; Tea; Urinary Bladder, Overactive	2018
Epigallocatechingallate attenuates myocardial injury in a mouse model of heart failure through TGF‑β1/Smad3 signaling pathway. Molecular medicine reports, 2018, Volume: 17, Issue:6 Topics: Animals; Apoptosis; Biomarkers; Catechin; Cytokines; Disease Models, Animal; Fibrosis; Heart Failure; Inflammation Mediators; Male; Mice; Myocardium; Oxidative Stress; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1; Ultrasonography	2018
Epigallocatechin-3-Gallate Protects and Prevents Paraquat-Induced Oxidative Stress and Neurodegeneration in Knockdown dj-1-β Drosophila melanogaster. Neurotoxicity research, 2018, Volume: 34, Issue:3 Topics: Animals; Animals, Genetically Modified; Antioxidants; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Drosophila melanogaster; Drosophila Proteins; Female; Herbicides; Lipid Peroxidation; Locomotion; Male; Minocycline; Nerve Tissue Proteins; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Paraquat; Protein Deglycase DJ-1; Tyrosine 3-Monooxygenase	2018
Epigallocatechin gallate targets FTO and inhibits adipogenesis in an mRNA m International journal of obesity (2005), 2018, Volume: 42, Issue:7 Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Anti-Obesity Agents; Catechin; Disease Models, Animal; Mice; RNA-Binding Proteins; RNA, Messenger; Tea	2018
Epigallocatechin-3-gallate protects against the exacerbation of allergic eosinophilic inflammation associated with obesity in mice. International immunopharmacology, 2018, Volume: 62 Topics: Animals; Antioxidants; Asthma; Catechin; Disease Models, Animal; Eosinophils; Inflammation; Lung; Male; Mice, Inbred C57BL; Obesity; Oxidative Stress	2018
Epigallocatechin Gallate Attenuates Bladder Dysfunction via Suppression of Oxidative Stress in a Rat Model of Partial Bladder Outlet Obstruction. Oxidative medicine and cellular longevity, 2018, Volume: 2018 Topics: Animals; Anticarcinogenic Agents; Catechin; Disease Models, Animal; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Urinary Bladder; Urinary Bladder Neck Obstruction	2018
Enhanced oral bioavailability of EGCG using pH-sensitive polymeric nanoparticles: characterization and in vivo investigation on nephrotic syndrome rats. Drug design, development and therapy, 2018, Volume: 12 Topics: Administration, Oral; Animals; Biological Availability; Calorimetry, Differential Scanning; Catechin; Crystallography, X-Ray; Disease Models, Animal; Drug Carriers; Drug Compounding; Drug Liberation; Hydrogen-Ion Concentration; Kidney; Microscopy, Electron, Transmission; Nanoparticles; Nephrotic Syndrome; Polymers; Powder Diffraction; Proteinuria; Rats, Sprague-Dawley; Renal Agents; Solubility	2018
Epigallocatechin‑3‑gallate protects against secondary osteoporosis in a mouse model via the Wnt/β‑catenin signaling pathway. Molecular medicine reports, 2018, Volume: 18, Issue:5 Topics: Animals; beta Catenin; Calcium; Cartilage; Catechin; Cell Proliferation; Cyclin D1; Disease Models, Animal; Humans; Mice; Osteoporosis; PPAR gamma; Tea; Wnt Signaling Pathway	2018
A New Therapeutic Approach for Brain Delivery of Epigallocatechin Gallate: Development and Characterization Studies. Current drug delivery, 2019, Volume: 16, Issue:1 Topics: Animals; Behavior, Animal; Biological Availability; Blood-Brain Barrier; Catechin; Cerebral Infarction; Disease Models, Animal; Drug Compounding; Drug Liberation; Emulsions; Humans; Lipids; Male; Memory Disorders; Mice; Nanoparticles; Neuroprotective Agents; Treatment Outcome	2019
Effects of Epigallocatechin Gallate on Behavioral and Cognitive Impairments, Hypothalamic-Pituitary-Adrenal Axis Dysfunction, and Alternations in Hippocampal BDNF Expression Under Single Prolonged Stress. Journal of medicinal food, 2018, Volume: 21, Issue:10 Topics: Animals; Brain-Derived Neurotrophic Factor; Catechin; Cognitive Dysfunction; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Hippocampus; Humans; Male; Maze Learning; Memory; Pituitary-Adrenal System; Rats; Stress Disorders, Post-Traumatic; Stress, Physiological	2018
Epigallocatechin-3 gallate prevents pressure overload-induced heart failure by up-regulating SERCA2a via histone acetylation modification in mice. PloS one, 2018, Volume: 13, Issue:10 Topics: Acetylation; Animals; Aortic Diseases; Cardiovascular Agents; Catechin; Constriction, Pathologic; Disease Models, Animal; Heart Failure; Histone Deacetylase 1; Histones; Male; Mice, Inbred C57BL; Promoter Regions, Genetic; Protective Agents; Random Allocation; RNA, Messenger; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Up-Regulation	2018
(‑)Epigallocatechin‑3‑gallate attenuates anesthesia‑induced memory deficit in young mice via modulation of nitric oxide expression. Molecular medicine reports, 2018, Volume: 18, Issue:6 Topics: Anesthesia; Animals; Antioxidants; Apoptosis; Arginine; Biomarkers; Catechin; Disease Models, Animal; Indazoles; Male; Memory; Memory Disorders; Mice; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase Type I; Oxidative Stress	2018
Effects of (-)-Epigallocatechin Gallate (EGCG) on Energy Expenditure and Microglia-Mediated Hypothalamic Inflammation in Mice Fed a High-Fat Diet. Nutrients, 2018, Nov-05, Volume: 10, Issue:11 Topics: Adipose Tissue, Brown; Animals; Biomarkers; Blood Glucose; Catechin; Cholesterol; Diet, High-Fat; Disease Models, Animal; Energy Metabolism; Hypothalamus; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Microglia; NF-kappa B; Obesity; Polyphenols; STAT3 Transcription Factor; Tea; Triglycerides	2018
G3BP1 promotes DNA binding and activation of cGAS. Nature immunology, 2019, Volume: 20, Issue:1 Topics: Animals; Autoantigens; Autoimmune Diseases of the Nervous System; Catechin; Clustered Regularly Interspaced Short Palindromic Repeats; Cytosol; Disease Models, Animal; DNA; DNA Helicases; Exodeoxyribonucleases; HEK293 Cells; HeLa Cells; Humans; Interferons; Mice; Mice, Knockout; Multiprotein Complexes; Nervous System Malformations; Neuroprotective Agents; Nucleotidyltransferases; Phosphoproteins; Poly-ADP-Ribose Binding Proteins; Protein Binding; RNA Helicases; RNA Recognition Motif Proteins	2019
Gelatin-epigallocatechin gallate nanoparticles with hyaluronic acid decoration as eye drops can treat rabbit dry-eye syndrome effectively via inflammatory relief. International journal of nanomedicine, 2018, Volume: 13 Topics: Animals; Catechin; Cell Survival; Cytokines; Disease Models, Animal; Dry Eye Syndromes; Epithelial Cells; Epithelium, Corneal; Gelatin; Humans; Hyaluronic Acid; Inflammation; Male; Nanoparticles; Ophthalmic Solutions; Particle Size; Rabbits; Rats; Sus scrofa; Tears; Treatment Outcome	2018
Development of transgenic Caenorhabditis elegans expressing human transthyretin as a model for drug screening. Scientific reports, 2018, 12-14, Volume: 8, Issue:1 Topics: Amyloid Neuropathies, Familial; Animals; Animals, Genetically Modified; Caenorhabditis elegans; Catechin; Disease Models, Animal; Drug Evaluation, Preclinical; Green Fluorescent Proteins; Humans; Locomotion; Longevity; Neuroprotective Agents; Prealbumin; Recombinant Fusion Proteins; Staining and Labeling	2018
"Cell-addictive" dual-target traceable nanodrug for Parkinson's disease treatment via flotillins pathway. Theranostics, 2018, Volume: 8, Issue:19 Topics: alpha-Synuclein; Animals; Animals, Genetically Modified; Catechin; Cell Line; Disease Models, Animal; Dopaminergic Neurons; Drug Carriers; Humans; Membrane Proteins; Mice; Molecular Targeted Therapy; Nanoparticles; Neuroprotective Agents; Parkinson Disease; Protein Aggregation, Pathological; Treatment Outcome	2018
Combined treatment with the phenolics (-)-epigallocatechin-3-gallate and ferulic acid improves cognition and reduces Alzheimer-like pathology in mice. The Journal of biological chemistry, 2019, 02-22, Volume: 294, Issue:8 Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Behavior, Animal; Catechin; Cognitive Dysfunction; Coumaric Acids; Disease Models, Animal; Drug Therapy, Combination; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Presenilin-1	2019
Diet supplemented with phytochemical epigallocatechin gallate and probiotic Lactobacillus fermentum confers second generation synbiotic effects by modulating cellular immune responses and antioxidant capacity in aging mice. European journal of nutrition, 2019, Volume: 58, Issue:7 Topics: Aging; Animals; Antioxidants; Catechin; Diet; Disease Models, Animal; Immunity, Cellular; Immunosenescence; Limosilactobacillus fermentum; Male; Mice; Oxidative Stress; Probiotics; Synbiotics	2019
RNA-seq analysis of diet-driven obesity and anti-obesity effects of quercetin glucoside or epigallocatechin gallate in Drosophila adults. European review for medical and pharmacological sciences, 2019, Volume: 23, Issue:2 Topics: Animals; Anti-Obesity Agents; Body Weight; Catechin; Diet, High-Fat; Disease Models, Animal; Drosophila; Drug Evaluation, Preclinical; Female; Gene Expression Regulation; Glucosides; Humans; Lipid Metabolism; Male; Metabolomics; Obesity; Oxidative Stress; Quercetin; RNA-Seq; RNA, Messenger; Species Specificity	2019
Tea's value as a cancer therapy is steeped in uncertainty. Nature, 2019, Volume: 566, Issue:7742 Topics: Animals; Biological Products; Case-Control Studies; Catechin; Cell Line, Tumor; China; Cohort Studies; Dietary Supplements; Disease Models, Animal; Female; Humans; Incidence; Japan; Life Style; Male; Metabolic Syndrome; Mice; Neoplasms; Plant Extracts; Prostatic Neoplasms; Sex Factors; Smoking; Sunitinib; Tea; Uncertainty	2019
Green tea catechins alleviate autoimmune symptoms and visual impairment in a murine model for human chronic intraocular inflammation by inhibiting Th17-associated pro-inflammatory gene expression. Scientific reports, 2019, 02-19, Volume: 9, Issue:1 Topics: Animals; Catechin; Disease Models, Animal; Electroretinography; Inflammation; Interleukin-17; Interleukin-6; Mice; Microscopy, Confocal; Papilledema; Tea; Th17 Cells; Tomography, Optical Coherence; Tumor Necrosis Factor-alpha; Uveitis; Vision Disorders	2019
Epigallocatechin-3-Gallate Attenuates Adriamycin-Induced Focal Segmental Glomerulosclerosis via Suppression of Oxidant Stress and Apoptosis by Targeting Hypoxia-Inducible Factor-1α/ Angiopoietin-Like 4 Pathway. Pharmacology, 2019, Volume: 103, Issue:5-6 Topics: Angiopoietin-Like Protein 4; Animals; Antioxidants; Apoptosis; Blotting, Western; Catechin; Disease Models, Animal; Doxorubicin; Fluorescent Antibody Technique; Glomerulosclerosis, Focal Segmental; Hypoxia-Inducible Factor 1, alpha Subunit; In Situ Nick-End Labeling; Mice; Mice, Inbred C57BL; Oxidative Stress; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction	2019
(-)-Epigallocatechin-3-Gallate Protects Against Lithium-Pilocarpine-Induced Epilepsy by Inhibiting the Toll-Like Receptor 4 (TLR4)/Nuclear Factor-κB (NF-κB) Signaling Pathway. Medical science monitor : international medical journal of experimental and clinical research, 2019, Mar-07, Volume: 25 Topics: Animals; Catechin; Disease Models, Animal; Epilepsy; Epilepsy, Temporal Lobe; Hippocampus; Lithium; Long-Term Potentiation; Male; Neurons; Neuroprotective Agents; NF-kappa B; Pilocarpine; Rats; Rats, Sprague-Dawley; Seizures; Signal Transduction; Toll-Like Receptor 4	2019
Prenatal treatment with EGCG enriched green tea extract rescues GAD67 related developmental and cognitive defects in Down syndrome mouse models. Scientific reports, 2019, 03-08, Volume: 9, Issue:1 Topics: Animals; Brain; Catechin; Cognition; Disease Models, Animal; Down Syndrome; Dyrk Kinases; Female; Glutamate Decarboxylase; Interneurons; Maternal-Fetal Exchange; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Pregnancy; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Tea	2019
Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model. Journal of controlled release : official journal of the Controlled Release Society, 2019, 05-10, Volume: 301 Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Ascorbic Acid; Brain; Catechin; Disease Models, Animal; Drug Carriers; Drug Liberation; Endothelial Cells; Male; Mice, Inbred C57BL; Mice, Transgenic; Nanoparticles; Polyethylene Glycols; Polylactic Acid-Polyglycolic Acid Copolymer; Rats	2019
Epigallocatechin gallate ameliorates airway inflammation by regulating Treg/Th17 imbalance in an asthmatic mouse model. International immunopharmacology, 2019, Volume: 72 Topics: Animals; Anti-Inflammatory Agents; Asthma; Catechin; Disease Models, Animal; Female; Forkhead Transcription Factors; Immunoglobulin E; Interleukin-10; Interleukin-17; Lung; Mice, Inbred BALB C; Nuclear Receptor Subfamily 1, Group F, Member 3; T-Lymphocytes, Regulatory; Th17 Cells	2019
Downregulated Wnt/β-catenin signalling in the Down syndrome hippocampus. Scientific reports, 2019, 05-13, Volume: 9, Issue:1 Topics: Adaptor Proteins, Signal Transducing; Aged; Alzheimer Disease; Animals; Axin Protein; Catechin; Chromosomes, Human, Pair 21; Disease Models, Animal; Down Syndrome; Down-Regulation; Dyrk Kinases; Female; HEK293 Cells; HeLa Cells; Hippocampus; Humans; Male; Mice; Middle Aged; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; RNA-Seq; Wnt Signaling Pathway	2019
Caffeine-free hawk tea lowers cholesterol by reducing free cholesterol uptake and the production of very-low-density lipoprotein. Communications biology, 2019, Volume: 2 Topics: Animals; Anticholesteremic Agents; Biological Transport, Active; Caffeine; Catechin; Cholesterol; Disease Models, Animal; Dyslipidemias; Feeder Cells; Gastrointestinal Microbiome; Hep G2 Cells; Humans; Kaempferols; Lipid Metabolism; Lipoproteins, VLDL; Litsea; Liver; Male; Models, Biological; Quercetin; Rats; Rats, Sprague-Dawley; Receptors, LDL; Sterol Regulatory Element Binding Protein 2; Teas, Medicinal	2019
Epigallocatechin-3-Gallate Prevents Acute Gout by Suppressing NLRP3 Inflammasome Activation and Mitochondrial DNA Synthesis. Molecules (Basel, Switzerland), 2019, Jun-06, Volume: 24, Issue:11 Topics: Animals; Caspase 1; Catechin; Disease Models, Animal; DNA, Mitochondrial; Gout; Humans; Inflammasomes; Inflammation; Interleukin-1beta; Macrophages; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Reactive Oxygen Species; Uric Acid	2019
Epigallocatechin-3-gallate ameliorates lipopolysaccharide-induced acute lung injury by suppression of TLR4/NF-κB signaling activation. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2019, Volume: 52, Issue:7 Topics: Acute Lung Injury; Animals; Catechin; Disease Models, Animal; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Signal Transduction; Toll-Like Receptor 4	2019
Low dose Epigallocatechin Gallate Alleviates Experimental Colitis by Subduing Inflammatory Cells and Cytokines, and Improving Intestinal Permeability. Nutrients, 2019, Jul-29, Volume: 11, Issue:8 Topics: Animals; Anti-Inflammatory Agents; Catechin; Colitis; Colon; Cytokines; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Agents; Inflammation Mediators; Macrophages; Male; Mice, Inbred C57BL; Permeability; T-Lymphocytes	2019
Protective effects of a catechin-rich extract on the hippocampal formation and spatial memory in aging rats. Behavioural brain research, 2013, Jun-01, Volume: 246 Topics: Age Factors; Animals; Catechin; Dendrites; Disease Models, Animal; Hippocampus; Lysosomes; Male; Malondialdehyde; Maze Learning; Memory Disorders; Microscopy, Electron, Transmission; Mitochondria; Neuroprotective Agents; Protein Carbonylation; Pyramidal Cells; Random Allocation; Rats; Rats, Wistar; Silver Staining; Space Perception	2013
Epigallocatechin-3-gallate is a potent phytochemical inhibitor of intimal hyperplasia in the wire-injured carotid artery. Journal of vascular surgery, 2013, Volume: 58, Issue:5 Topics: Animals; Cardiovascular Agents; Carotid Artery Injuries; Carotid Artery, Common; Carotid Intima-Media Thickness; Catechin; Cell Proliferation; Disease Models, Animal; Disulfides; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Hyperplasia; Injections, Intraperitoneal; Isothiocyanates; Male; Neointima; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Sulfinic Acids; Sulfoxides; Time Factors	2013
Green tea epigallocatechin-3-gallate attenuates Porphyromonas gingivalis-induced atherosclerosis. Pathogens and disease, 2013, Volume: 67, Issue:1 Topics: Animals; Anti-Inflammatory Agents; Aorta; Atherosclerosis; Bacteroidaceae Infections; Biomarkers; Catechin; Disease Models, Animal; Gene Expression Profiling; Male; Mice; Mice, Knockout; Porphyromonas gingivalis; Tea Tree Oil; Treatment Outcome	2013
[Research on EGCG improving the degenerative changes of the brain in AD model mice induced with chemical drugs]. Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2012, Volume: 35, Issue:10 Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Catechin; Disease Models, Animal; Female; Galactose; Gene Expression Regulation; Hippocampus; Mice; Neurons; Neuroprotective Agents; Phytotherapy; Tea	2012
(-)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP/PS1 mice by restoring IRS-1 signaling defects in the hippocampus. Molecular and cellular biochemistry, 2013, Volume: 380, Issue:1-2 Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Blotting, Western; Catechin; Disease Models, Animal; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Immunohistochemistry; Insulin Receptor Substrate Proteins; JNK Mitogen-Activated Protein Kinases; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Peptide Fragments; Phosphorylation; Presenilin-1; Proto-Oncogene Proteins c-akt; Serine; Signal Transduction; Tumor Necrosis Factor-alpha	2013
Epigallocatechin-3-gallate reduces myometrial infiltration, uterine hyperactivity, and stress levels and alleviates generalized hyperalgesia in mice induced with adenomyosis. Reproductive sciences (Thousand Oaks, Calif.), 2013, Volume: 20, Issue:12 Topics: Adenomyosis; Animals; Biomarkers; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hydrocortisone; Hyperalgesia; Mice; Mice, Inbred ICR; Myometrium; Pain Threshold; Reaction Time; Stress, Physiological; Tamoxifen; Time Factors; Uterine Contraction	2013
Anti-edema effect of epigallocatechin gallate on spinal cord injury in rats. Brain research, 2013, Aug-21, Volume: 1527 Topics: Animals; Aquaporin 4; Blotting, Western; Catechin; Disease Models, Animal; Edema; Glial Fibrillary Acidic Protein; Immunohistochemistry; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries	2013
Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization. BMC cancer, 2013, Sep-17, Volume: 13 Topics: Animals; Anticarcinogenic Agents; Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Proliferation; Chemokine CCL2; Disease Models, Animal; Exosomes; Female; Gene Expression Regulation, Neoplastic; I-kappa B Kinase; I-kappa B Proteins; Macrophage Colony-Stimulating Factor; Macrophages; Mice; MicroRNAs; Paracrine Communication	2013
Neuroprotection by (-)-epigallocatechin-3-gallate in a rat model of stroke is mediated through inhibition of endoplasmic reticulum stress. Molecular medicine reports, 2014, Volume: 9, Issue:1 Topics: Animals; Apoptosis; Caspase 12; Catechin; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Endoplasmic Reticulum Stress; Flavonoids; Heat-Shock Proteins; Male; Mitogen-Activated Protein Kinase Kinases; Neuroprotective Agents; Phosphorylation; Rats; Rats, Sprague-Dawley; Signal Transduction; Spectrin; Stroke; Transcription Factor CHOP; TRPC Cation Channels	2014
Epigallocatechin-3-gallate prevents tumor cell implantation/growth in an experimental rat bladder tumor model. International journal of oncology, 2014, Volume: 44, Issue:1 Topics: Animals; Catechin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Female; Humans; Mitomycin; Neoplasms, Experimental; Rats; Urinary Bladder Neoplasms	2014
Epigallocatechin-3-gallate prevents autoimmune-associated down- regulation of p21 in salivary gland cells through a p53-independent pathway. Inflammation & allergy drug targets, 2014, Volume: 13, Issue:1 Topics: Animals; Anticarcinogenic Agents; Catechin; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Diabetes Mellitus, Type 1; Disease Models, Animal; Down-Regulation; Epithelial Cells; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Proliferating Cell Nuclear Antigen; Retinoblastoma Protein; Salivary Glands; Sjogren's Syndrome; Tumor Suppressor Protein p53; Xerostomia	2014
Epigallocatechin-3-gallate (EGCG) attenuates concanavalin A-induced hepatic injury in mice. Acta histochemica, 2014, Volume: 116, Issue:4 Topics: Animals; Catechin; Chemical and Drug Induced Liver Injury; Concanavalin A; Disease Models, Animal; Male; Mice, Inbred C57BL; Oxidative Stress; Toll-Like Receptors; Tumor Necrosis Factor-alpha	2014
Epigallocatechin gallate inhibits oxidative stress-induced DNA damage and apoptosis in MRL-Fas(lpr) mice with autoimmune sialadenitis via upregulation of heme oxygenase-1 and Bcl-2. Autoimmunity, 2014, Volume: 47, Issue:1 Topics: Animals; Antioxidants; Apoptosis; Autoantigens; Autoimmune Diseases; Catechin; Disease Models, Animal; DNA Damage; Gene Expression Regulation; Heme Oxygenase-1; Mice; Mice, Inbred MRL lpr; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Severity of Illness Index; Sialadenitis; Submandibular Gland	2014
Dietary supplementation with a low dose of (-)-epigallocatechin-3-gallate reduces pro-inflammatory responses in peripheral leukocytes of non-obese type 2 diabetic GK rats. Journal of nutritional science and vitaminology, 2013, Volume: 59, Issue:6 Topics: 8-Hydroxy-2'-Deoxyguanosine; Analysis of Variance; Animals; Catechin; Chemokines; Corn Oil; Cytokines; Deoxyguanosine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet; Diet, High-Fat; Dietary Fats; Dietary Supplements; Disease Models, Animal; Inflammation; Leukocytes; Male; Malondialdehyde; Oxidative Stress; Polymerase Chain Reaction; Rats; Rats, Wistar	2013
Epigallocatechin-3-gallate restores the Bcl-2 expression in liver of young rats challenged with hypercholesterolemia but not in aged rats: an insight into its disparity of efficacy on advancing age. Food & function, 2014, Volume: 5, Issue:5 Topics: Age Factors; Animals; Apoptosis; Catechin; Disease Models, Animal; Humans; Hypercholesterolemia; Liver; Male; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar	2014
Effect of topical epigallocatechin gallate on corneal neovascularization in rabbits. Cornea, 2014, Volume: 33, Issue:5 Topics: Administration, Topical; Angiogenesis Inhibitors; Animals; Antioxidants; Blotting, Western; Catechin; Cornea; Corneal Neovascularization; Cyclooxygenase 2; Disease Models, Animal; Electrophoresis, Polyacrylamide Gel; Ophthalmic Solutions; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vascular Endothelial Growth Factor A	2014
(-)-Epigallocatechin-3-gallate attenuated myocardial mitochondrial dysfunction and autophagy in diabetic Goto-Kakizaki rats. Free radical research, 2014, Volume: 48, Issue:8 Topics: Animals; Autophagy; Catechin; Diabetes Mellitus, Experimental; Disease Models, Animal; Male; Mitochondria, Heart; Oxidative Stress; Rats; Rats, Wistar	2014
(-)-Epigallocatechin-3-gallate modulates spinal cord neuronal degeneration by enhancing growth-associated protein 43, B-cell lymphoma 2, and decreasing B-cell lymphoma 2-associated x protein expression after sciatic nerve crush injury. Journal of neurotrauma, 2015, Feb-01, Volume: 32, Issue:3 Topics: Animals; bcl-X Protein; Catechin; Disease Models, Animal; GAP-43 Protein; Immunohistochemistry; Male; Nerve Crush; Nerve Degeneration; Neuroprotective Agents; Peripheral Nerve Injuries; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Recovery of Function; Reverse Transcriptase Polymerase Chain Reaction; Sciatic Nerve; Spinal Cord	2015
Amelioration of lipid profile and level of antioxidant activities by epigallocatechin-gallate in a rat model of atherogenesis. Heart, lung & circulation, 2014, Volume: 23, Issue:12 Topics: Animals; Antioxidants; Atherosclerosis; Catechin; Diet, Atherogenic; Disease Models, Animal; Lipids; Male; Rats; Rats, Wistar	2014
Epigallocatechin-3-gallate and tetracycline differently affect ataxin-3 fibrillogenesis and reduce toxicity in spinocerebellar ataxia type 3 model. Human molecular genetics, 2014, Dec-15, Volume: 23, Issue:24 Topics: Amyloid; Animals; Ataxin-3; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Catechin; Cell Survival; Chlorocebus aethiops; COS Cells; Disease Models, Animal; Gene Expression; Green Fluorescent Proteins; Humans; Hydrogen Bonding; Machado-Joseph Disease; Microscopy, Atomic Force; Nerve Tissue Proteins; Neuroprotective Agents; Protein Aggregates; Recombinant Fusion Proteins; Spectroscopy, Fourier Transform Infrared; Tetracycline	2014
Green tea extract treatment alleviates ocular inflammation in a rat model of endotoxin-induced uveitis. PloS one, 2014, Volume: 9, Issue:8 Topics: Animals; Aqueous Humor; Catechin; Disease Models, Animal; Endotoxins; Inflammation; Lipopolysaccharides; Neutrophil Infiltration; Plant Extracts; Rats; Rats, Sprague-Dawley; Tea; Uveitis	2014
The therapeutic effects of EGCG on vitiligo. Fitoterapia, 2014, Volume: 99 Topics: Animals; Anti-Inflammatory Agents; Catechin; CD8-Positive T-Lymphocytes; Disease Models, Animal; Female; Hydroquinones; Interferon-gamma; Interleukin-6; Melanocytes; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Skin Pigmentation; Transcriptome; Tumor Necrosis Factor-alpha; Vitiligo	2014
Tea component, epigallocatechin gallate, potentiates anticataleptic and locomotor-sensitizing effects of caffeine in mice. Behavioural pharmacology, 2015, Volume: 26, Issue:1-2 Topics: Animals; Antipsychotic Agents; Caffeine; Catalepsy; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Lipid Peroxidation; Male; Mice; Motor Activity; Parkinsonian Disorders; Tea	2015
Epigallocatechin-3-gallate protects against cisplatin nephrotoxicity by inhibiting the apoptosis in mouse. International journal of clinical and experimental pathology, 2014, Volume: 7, Issue:8 Topics: Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Catechin; Cisplatin; Disease Models, Animal; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL	2014
[Effects of EGCG on learning and memory ability expression level of NMDA receptor NR1 subunit protein in the brain of fatigue rats]. Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology, 2014, Volume: 30, Issue:3 Topics: Animals; Catechin; Disease Models, Animal; Fatigue; Learning; Male; Memory; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate	2014
Beneficial effects of dietary EGCG and voluntary exercise on behavior in an Alzheimer's disease mouse model. Journal of Alzheimer's disease : JAD, 2015, Volume: 44, Issue:2 Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Anxiety; Catechin; Cerebral Cortex; Disease Models, Animal; Drinking Water; Female; Hippocampus; Housing, Animal; Humans; Male; Maze Learning; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Nootropic Agents; Peptide Fragments	2015
Novel Epigenetic Regulation of Alpha-Synuclein Expression in Down Syndrome. Molecular neurobiology, 2016, Volume: 53, Issue:1 Topics: alpha-Synuclein; Animals; Catechin; Disease Models, Animal; DNA Methylation; Down Syndrome; Epigenesis, Genetic; Mice; Promoter Regions, Genetic	2016
Green tea polyphenol treatment is chondroprotective, anti-inflammatory and palliative in a mouse post-traumatic osteoarthritis model. Arthritis research & therapy, 2014, Dec-17, Volume: 16, Issue:6 Topics: Animals; Anti-Inflammatory Agents; Cartilage, Articular; Catechin; Chondrocytes; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Osteoarthritis; Palliative Care; Polyphenols; Tea	2014
Hippocampal Neuroprotection by Minocycline and Epigallo-Catechin-3-Gallate Against Cardiopulmonary Bypass-Associated Injury. Brain pathology (Zurich, Switzerland), 2015, Volume: 25, Issue:6 Topics: Adenosine Triphosphate; Animals; Apoptosis Inducing Factor; Brain Edema; CA1 Region, Hippocampal; CA3 Region, Hippocampal; Cardiopulmonary Bypass; Caspase 3; Catechin; Chromatography, High Pressure Liquid; Disease Models, Animal; Hypoxia-Inducible Factor 1, alpha Subunit; Minocycline; Neuroprotective Agents; Poly Adenosine Diphosphate Ribose; Swine; Tyrosine	2015
Epigallocatechin-3-Gallate Attenuates Oxidative Stress and Inflammation in Obstructive Nephropathy via NF-κB and Nrf2/HO-1 Signalling Pathway Regulation. Basic & clinical pharmacology & toxicology, 2015, Volume: 117, Issue:3 Topics: Animals; Bilirubin; Catechin; Disease Models, Animal; Electrophoretic Mobility Shift Assay; Heme Oxygenase-1; Inflammation; Kidney; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Signal Transduction; Ureteral Obstruction	2015
(-) Epigallocatechin-3-gallate attenuates reserpine-induced orofacial dyskinesia and oxidative stress in rat striatum. Pharmacology, biochemistry, and behavior, 2015, Volume: 131 Topics: Animals; Catalase; Catechin; Corpus Striatum; Disease Models, Animal; Glutathione; Lipid Peroxidation; Male; Movement Disorders; Oxidative Stress; Rats; Rats, Wistar; Reserpine; Superoxide Dismutase	2015
Epigallocatechin-3-gallate protects against cisplatin-induced nephrotoxicity by inhibiting endoplasmic reticulum stress-induced apoptosis. Experimental biology and medicine (Maywood, N.J.), 2015, Volume: 240, Issue:11 Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Apoptosis; Caspase 12; Catechin; Cisplatin; Disease Models, Animal; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Extracellular Signal-Regulated MAP Kinases; Heat-Shock Proteins; Kidney; Male; Mice; Mice, Inbred C57BL; Phosphorylation	2015
Effect of epigallocatechin gallate on uncoupling protein 2 in acute liver injury. International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:1 Topics: Animals; Antioxidants; Catechin; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Ion Channels; Male; Mitochondrial Proteins; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Thioacetamide; Uncoupling Protein 2	2015
Epigallocatechin-3-gallate attenuates lipopolysaccharide-induced mastitis in rats via suppressing MAPK mediated inflammatory responses and oxidative stress. International immunopharmacology, 2015, Volume: 26, Issue:1 Topics: Animals; Blotting, Western; Catechin; Disease Models, Animal; Female; Lipopolysaccharides; Male; Mammary Glands, Animal; Mastitis; Mitogen-Activated Protein Kinase Kinases; Oxidative Stress; Pregnancy; Rats, Sprague-Dawley	2015
Epigallocatechin gallate stimulates the neuroreactive salivary secretomotor system in autoimmune sialadenitis of MRL-Fas(lpr) mice via activation of cAMP-dependent protein kinase A and inactivation of nuclear factor κB. Autoimmunity, 2015, Volume: 48, Issue:6 Topics: Animals; Aquaporin 5; Autoimmune Diseases; Catechin; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Gene Expression Regulation; Histone Deacetylase 1; Immunohistochemistry; JNK Mitogen-Activated Protein Kinases; Mice; Mice, Inbred MRL lpr; NF-kappa B; Protein Subunits; Reactive Oxygen Species; Salivary Glands; Sialadenitis; Submandibular Gland	2015
[Efficacy of epigallocatechin gallate in treatment of alkali burn injury of murine cornea]. Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2015, Volume: 44, Issue:1 Topics: Alkalies; Animals; Burns, Chemical; Catechin; Cornea; Corneal Neovascularization; Disease Models, Animal; Eye Burns; Inflammation; Mice; Mice, Inbred C57BL; Neutrophils; RNA, Messenger; Vascular Endothelial Growth Factor A	2015
(-)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer's disease model mice by upregulating neprilysin expression. Experimental cell research, 2015, May-15, Volume: 334, Issue:1 Topics: Alzheimer Disease; Animals; Catechin; Cell Proliferation; Cells, Cultured; CHO Cells; Cognition Disorders; Cricetulus; Disease Models, Animal; Mice; Neprilysin; Stereoisomerism; Up-Regulation	2015
Green tea polyphenol epigallocatechin-3-gallate ameliorates insulin resistance in non-alcoholic fatty liver disease mice. Acta pharmacologica Sinica, 2015, Volume: 36, Issue:5 Topics: Animals; Biomarkers; Blood Glucose; Camellia sinensis; Catechin; Diet, High-Fat; Disease Models, Animal; Dose-Response Relationship, Drug; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulysin; Liver; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Phytotherapy; Plants, Medicinal; Time Factors	2015
Epigallocatechin 3-gallate ameliorates bile duct ligation induced liver injury in mice by modulation of mitochondrial oxidative stress and inflammation. PloS one, 2015, Volume: 10, Issue:5 Topics: Animals; Bile Ducts, Intrahepatic; Catechin; Cell Death; Cholestasis; Cytokines; Disease Models, Animal; Gene Expression Regulation; Hepatic Stellate Cells; Hepatocytes; Inflammation; Liver Cirrhosis; Mice; Mitochondria; NF-kappa B; Oxidative Stress	2015
Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet. European journal of pharmacology, 2015, Aug-15, Volume: 761 Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Catechin; Choline Deficiency; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Inflammation Mediators; Lipids; Liver; Male; Methionine; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Signal Transduction; Transforming Growth Factor beta	2015
Biochemical and histopathological effects of catechin on experimental peripheral nerve injuries. Turkish neurosurgery, 2015, Volume: 25, Issue:3 Topics: Animals; Catechin; Disease Models, Animal; Male; Neuroprotective Agents; Peripheral Nerve Injuries; Rats; Rats, Wistar	2015
Protective effects of epigallocatechin-3-gallate on intestinal ischemia reperfusion injury through enhanced activation of PI3K/Akt pathway in rats. Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2015, Volume: 35, Issue:3 Topics: Animals; Anti-Inflammatory Agents; Catechin; Disease Models, Animal; Gene Expression Regulation; Interleukin-1; Interleukin-6; Intestines; Male; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Reperfusion Injury; Signal Transduction; Tumor Necrosis Factor-alpha	2015
Paraventricular Nucleus Infusion of Epigallocatechin-3-O-Gallate Improves Renovascular Hypertension. Cardiovascular toxicology, 2016, Volume: 16, Issue:3 Topics: Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Antioxidants; Blood Pressure; Catechin; Cytokines; Disease Models, Animal; Hypertension, Renovascular; Infusions, Parenteral; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Oxidative Stress; Paraventricular Hypothalamic Nucleus; Rats, Sprague-Dawley; Superoxide Dismutase-1; Time Factors	2016
Rescue of the abnormal skeletal phenotype in Ts65Dn Down syndrome mice using genetic and therapeutic modulation of trisomic Dyrk1a. Human molecular genetics, 2015, Oct-15, Volume: 24, Issue:20 Topics: Animals; Bone Diseases; Catechin; Disease Models, Animal; Down Syndrome; Dyrk Kinases; Gene Dosage; Male; Mice; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases	2015
[Study on inhibitory effect of EGCG on Calcium oxalate nephrolithiasis in rats and its related mechanism]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2015, Volume: 40, Issue:7 Topics: Animals; Blood Urea Nitrogen; Calcium; Calcium Oxalate; Catechin; Creatinine; Disease Models, Animal; Humans; Kidney; Male; Nephrolithiasis; Osteopontin; Rats; Rats, Wistar	2015
EGCG induces G-CSF expression and neutrophilia in experimental sepsis. Immunologic research, 2015, Volume: 63, Issue:1-3 Topics: Animals; Anti-Inflammatory Agents; Catechin; Cells, Cultured; Chemokines; Disease Models, Animal; Granulocyte Colony-Stimulating Factor; HMGB1 Protein; Humans; Leukocytes, Mononuclear; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; Neutrophils; Sepsis; Tea	2015
Prevention of hepatitis C virus infection using a broad cross-neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2016, Volume: 22, Issue:3 Topics: Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antiviral Agents; Broadly Neutralizing Antibodies; Catechin; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Genotype; Hepatitis C; Hepatitis Viruses; Humans; Liver; Mice, SCID; Time Factors	2016
QIAD assay for quantitating a compound's efficacy in elimination of toxic Aβ oligomers. Scientific reports, 2015, Sep-23, Volume: 5 Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Carrier Proteins; Catechin; Disease Models, Animal; Ferredoxin-NADP Reductase; Humans; Inositol; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Transgenic; Oligopeptides; Protein Aggregation, Pathological; Taurine	2015
Dressing with epigallocatechin gallate nanoparticles for wound regeneration. Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society, 2016, Volume: 24, Issue:2 Topics: Animals; Anti-Bacterial Agents; Bandages; Biocompatible Materials; Catechin; Cells, Cultured; Chitosan; Disease Models, Animal; Drug Delivery Systems; Fibroblasts; Gelatin; Gentamicins; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Male; Materials Testing; Nanoparticles; Polyglutamic Acid; Rats; Rats, Sprague-Dawley; Re-Epithelialization; Wound Healing; Wounds and Injuries	2016
Regulation of Transforming Growth Factor β-Activated Kinase Activation by Epigallocatechin-3-Gallate in Rheumatoid Arthritis Synovial Fibroblasts: Suppression of K(63) -Linked Autoubiquitination of Tumor Necrosis Factor Receptor-Associated Factor 6. Arthritis & rheumatology (Hoboken, N.J.), 2016, Volume: 68, Issue:2 Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Blotting, Western; Catechin; Disease Models, Animal; Female; Fibroblasts; Humans; Immunoprecipitation; In Vitro Techniques; Interleukin-1 Receptor-Associated Kinases; Interleukin-1beta; Interleukin-6; Interleukin-8; Lysine; MAP Kinase Kinase Kinases; Molecular Docking Simulation; Proteasome Endopeptidase Complex; Protein Processing, Post-Translational; Rats; Rats, Inbred Lew; Synovial Membrane; TNF Receptor-Associated Factor 6; Ubiquitination	2016
Green Tea Polyphenol Prevents Diabetic Rats From Acute Kidney Injury After Cardiopulmonary Bypass. The Annals of thoracic surgery, 2016, Volume: 101, Issue:4 Topics: Acute Kidney Injury; Administration, Oral; Animals; Biopsy, Needle; Cardiopulmonary Bypass; Catechin; Diabetes Mellitus, Experimental; Disease Models, Animal; Follow-Up Studies; Immunohistochemistry; Kidney Function Tests; Male; Polyphenols; Preoperative Care; Random Allocation; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Reference Values; Risk Assessment; Tea; Treatment Outcome	2016
Differential effects of Epigallocatechin-3-gallate containing supplements on correcting skeletal defects in a Down syndrome mouse model. Molecular nutrition & food research, 2016, Volume: 60, Issue:4 Topics: Absorptiometry, Photon; Animals; Bone and Bones; Catechin; Dietary Supplements; Disease Models, Animal; Down Syndrome; Female; Femur; Male; Mice, Inbred C57BL; Mice, Mutant Strains; X-Ray Microtomography	2016
Epigallocatechin Gallate Extends the Therapeutic Window of Recombinant Tissue Plasminogen Activator Treatment in Ischemic Rats. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2016, Volume: 25, Issue:4 Topics: Animals; Blood-Brain Barrier; Brain Edema; Catechin; Disease Models, Animal; Drug Therapy, Combination; Fibrinolytic Agents; Gene Expression Regulation; Infarction, Middle Cerebral Artery; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 9; Neuroprotective Agents; Permeability; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; Sensory Gating; Time Factors; Tissue Plasminogen Activator; Treatment Outcome	2016
The Effect of Epigallocatechin Gallate on Flap Viability of Rat Perforator Abdominal Flaps. Journal of reconstructive microsurgery, 2016, Volume: 32, Issue:4 Topics: Abdomen; Angiogenesis Inducing Agents; Animals; Catechin; Disease Models, Animal; Female; Graft Survival; Perforator Flap; Plastic Surgery Procedures; Rats; Rats, Wistar; Regional Blood Flow	2016
Nitric oxide pathway activity modulation alters the protective effects of (-)Epigallocatechin-3-gallate on reserpine-induced impairment in rats. Behavioural brain research, 2016, May-15, Volume: 305 Topics: Animals; Arginine; Catechin; Discrimination, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Exploratory Behavior; Glutathione; Hippocampus; Lipid Peroxidation; Male; Memory Disorders; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Reserpine; Signal Transduction; Smell; Superoxide Dismutase	2016
Epigallocatechin-3-gallate ameliorates autoimmune arthritis by reciprocal regulation of T helper-17 regulatory T cells and inhibition of osteoclastogenesis by inhibiting STAT3 signaling. Journal of leukocyte biology, 2016, Volume: 100, Issue:3 Topics: Animals; Antioxidants; Arthritis, Experimental; Autoimmune Diseases; Catechin; Cell Differentiation; Cells, Cultured; Disease Models, Animal; Male; Mice; Mice, Inbred DBA; Mice, Knockout; Osteoclasts; Osteogenesis; Signal Transduction; STAT3 Transcription Factor; T-Lymphocytes, Regulatory; Th17 Cells	2016
The polyphenols resveratrol and epigallocatechin-3-gallate restore the severe impairment of mitochondria in hippocampal progenitor cells from a Down syndrome mouse model. Biochimica et biophysica acta, 2016, Volume: 1862, Issue:6 Topics: Adenosine Triphosphate; AMP-Activated Protein Kinase Kinases; Animals; Antioxidants; Catechin; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Down Syndrome; Female; Hippocampus; Male; Mice; Mitochondria; Neural Stem Cells; Neurogenesis; Neuroprotective Agents; Protein Kinases; Resveratrol	2016
Epigallocatechin-3-Gallate Inhibition of Myeloperoxidase and Its Counter-Regulation by Dietary Iron and Lipocalin 2 in Murine Model of Gut Inflammation. The American journal of pathology, 2016, Volume: 186, Issue:4 Topics: Acute-Phase Proteins; Animals; Antioxidants; Catechin; Dextran Sulfate; Disease Models, Animal; Humans; Inflammation; Iron, Dietary; Lipocalin-2; Lipocalins; Mice, Inbred C57BL; Oncogene Proteins; Peroxidase; Proto-Oncogene Proteins; Tea	2016
Neurorestorative effects of epigallocatechin-3-Gallate on cognitive function in a chronic cerebral hypoperfusion rat model. Restorative neurology and neuroscience, 2016, 04-11, Volume: 34, Issue:3 Topics: Animals; Brain-Derived Neurotrophic Factor; Catechin; Cerebrovascular Disorders; Cognition Disorders; Disease Models, Animal; Drug Administration Routes; Escape Reaction; Hippocampus; Male; Malondialdehyde; Maze Learning; Neuroprotective Agents; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Superoxide Dismutase; Vascular Endothelial Growth Factor A	2016
(-)-Epigallocatechin-3-gallate decreases colonic inflammation and permeability in a mouse model of colitis, but reduces macronutrient digestion and exacerbates weight loss. Molecular nutrition & food research, 2016, Volume: 60, Issue:10 Topics: Animals; Biomarkers; Caco-2 Cells; Catechin; Chemokine CCL2; Colitis, Ulcerative; Dextran Sulfate; Digestion; Disease Models, Animal; Humans; Intestinal Absorption; Male; Mice, Inbred Strains; Oxidative Stress; Permeability; Weight Loss	2016
Epigallocatechin gallate exerts protective effects against myocardial ischemia/reperfusion injury through the PI3K/Akt pathway-mediated inhibition of apoptosis and the restoration of the autophagic flux. International journal of molecular medicine, 2016, Volume: 38, Issue:1 Topics: Animals; Apoptosis; Autophagy; Cardiotonic Agents; Catechin; Creatine Kinase, MB Form; Disease Models, Animal; Hemodynamics; L-Lactate Dehydrogenase; Male; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; TOR Serine-Threonine Kinases	2016
Strong Inhibition of Secretory Sphingomyelinase by Catechins, Particularly by (-)-Epicatechin 3-O-Gallate and (-)-3'-O-Methylepigallocatechin 3-O-Gallate. Journal of nutritional science and vitaminology, 2016, Volume: 62, Issue:2 Topics: Animals; Atherosclerosis; Catechin; Diabetes Mellitus, Type 2; Disease Models, Animal; Hydrogen-Ion Concentration; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Sphingomyelin Phosphodiesterase	2016
Synergistic Effect of Artificial Tears Containing Epigallocatechin Gallate and Hyaluronic Acid for the Treatment of Rabbits with Dry Eye Syndrome. PloS one, 2016, Volume: 11, Issue:6 Topics: Animals; Catechin; Cytokines; Disease Models, Animal; Drug Synergism; Dry Eye Syndromes; Epithelial Cells; Epithelium, Corneal; Gene Expression Profiling; Humans; Hyaluronic Acid; Inflammation Mediators; Lubricant Eye Drops; Male; Rabbits	2016
Protective potential of epigallocatechin-3-gallate against benign prostatic hyperplasia in metabolic syndrome rats. Environmental toxicology and pharmacology, 2016, Volume: 45 Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Catechin; Cytokines; Disease Models, Animal; Male; Metabolic Syndrome; Oxidative Stress; Peroxisome Proliferator-Activated Receptors; Prostatic Hyperplasia; Rats, Sprague-Dawley; Somatomedins	2016
EGCG Suppresses ERK5 Activation to Reverse Tobacco Smoke-Triggered Gastric Epithelial-Mesenchymal Transition in BALB/c Mice. Nutrients, 2016, Jul-20, Volume: 8, Issue:7 Topics: Animals; Anticarcinogenic Agents; Benzodiazepinones; Biomarkers, Tumor; Carcinogenesis; Catechin; Dietary Supplements; Disease Models, Animal; Enzyme Activation; Epithelial-Mesenchymal Transition; Gastric Mucosa; Gene Expression Regulation, Neoplastic; Injections, Intraperitoneal; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase 7; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Random Allocation; Smoking; Stomach Neoplasms	2016
Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome. Neuroscience, 2016, 10-01, Volume: 333 Topics: Animals; Catechin; Cognition; Disease Models, Animal; Down Syndrome; Female; Hippocampus; Male; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Transgenic; Neocortex; Neural Pathways; Neurogenesis; Neuroprotective Agents; Synapses; Time Factors	2016
Green tea (-)-epigallocatechin-3-gallate counteracts daytime overeating induced by high-fat diet in mice. Molecular nutrition & food research, 2016, Volume: 60, Issue:12 Topics: Animals; Antioxidants; Catechin; Diet, High-Fat; Disease Models, Animal; Feeding Behavior; Homeostasis; Hyperphagia; Hypothalamus; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Tea	2016
Prevention of abdominal aortic aneurysm progression by oral administration of green tea polyphenol in a rat model. Journal of vascular surgery, 2017, Volume: 65, Issue:6 Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Calcium Chloride; Catechin; Collagen; Cytokines; Dilatation, Pathologic; Disease Models, Animal; Disease Progression; Elastin; Gene Expression Regulation; Inflammation Mediators; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 9; Pancreatic Elastase; Phytotherapy; Plant Extracts; Plants, Medicinal; Polyphenols; Protein-Lysine 6-Oxidase; Rats, Sprague-Dawley; Tea; Time Factors; Tropoelastin	2017
Epigallocatechin-3-gallate Attenuates Renal Damage by Suppressing Oxidative Stress in Diabetic db/db Mice. Oxidative medicine and cellular longevity, 2016, Volume: 2016 Topics: Animals; Catechin; Diabetes Insipidus, Nephrogenic; Disease Models, Animal; Kidney; Mice; Mice, Inbred C57BL; Oxidative Stress	2016
Epigallocatechin-3-gallate protects against hepatic ischaemia-reperfusion injury by reducing oxidative stress and apoptotic cell death. The Journal of international medical research, 2016, Volume: 44, Issue:6 Topics: Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Catechin; Cytochromes c; Disease Models, Animal; Glutathione; Glutathione Disulfide; Inflammation; Injections, Intraperitoneal; Lipid Peroxidation; Liver; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Reperfusion Injury	2016
Epigallocatechin-3-gallate promotes angiogenesis via up-regulation of Nfr2 signaling pathway in a mouse model of ischemic stroke. Behavioural brain research, 2017, 03-15, Volume: 321 Topics: Angiogenesis Inducing Agents; Animals; Brain; Catechin; Disease Models, Animal; Flavonoids; Infarction, Middle Cerebral Artery; Male; Mice, Inbred C57BL; Neovascularization, Physiologic; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Protein Kinase Inhibitors; Random Allocation; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2	2017
The Green Tea Catechin Epigallocatechin Gallate Ameliorates Graft-versus-Host Disease. PloS one, 2017, Volume: 12, Issue:1 Topics: Alkaloids; Allografts; Animals; Antioxidants; Benzodioxoles; Catechin; Disease Models, Animal; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neovascularization, Pathologic; Oxidative Stress; Piperidines; Polyunsaturated Alkamides; Quercetin; T-Lymphocytes, Regulatory; Tea	2017
Preparation of arginine-glycine-aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization. International journal of nanomedicine, 2017, Volume: 12 Topics: Angiogenesis Inhibitors; Animals; Burns, Chemical; Catechin; Cell Survival; Corneal Neovascularization; Disease Models, Animal; Eye Burns; Human Umbilical Vein Endothelial Cells; Humans; Hyaluronic Acid; Integrin alphaVbeta3; Mice, Inbred C57BL; Molecular Targeted Therapy; Nanoparticles; Oligopeptides; Ophthalmic Solutions	2017
Targeted nanoparticles encapsulating (-)-epigallocatechin-3-gallate for prostate cancer prevention and therapy. Scientific reports, 2017, 02-01, Volume: 7 Topics: Animals; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Drug Carriers; Drug Compounding; Drug Liberation; Humans; Kinetics; Ligands; Male; Mice; Molecular Conformation; Molecular Targeted Therapy; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Prostatic Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays	2017
Influence of prenatal EGCG treatment and Dyrk1a dosage reduction on craniofacial features associated with Down syndrome. Human molecular genetics, 2016, 11-15, Volume: 25, Issue:22 Topics: Animals; Catechin; Craniofacial Abnormalities; Disease Models, Animal; Down Syndrome; Dyrk Kinases; Female; Gene Dosage; Mice; Phenotype; Phosphorylation; Pregnancy; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases	2016
A green tea component suppresses posttranslational expression of basic fibroblast growth factor in colorectal cancer. Gastroenterology, 2008, Volume: 134, Issue:7 Topics: Acetylcysteine; Adenomatous Polyposis Coli; Animals; Antineoplastic Agents, Phytogenic; Camellia sinensis; Catechin; Cell Transformation, Neoplastic; Colorectal Neoplasms; Cycloheximide; Cysteine Proteinase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Fibroblast Growth Factor 2; Genes, APC; HCT116 Cells; HT29 Cells; Humans; Mice; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Processing, Post-Translational; Protein Synthesis Inhibitors; Time Factors; Transfection	2008
(-)-Epigallocatechin-3-gallate suppresses osteoclast differentiation and ameliorates experimental arthritis in mice. Arthritis and rheumatism, 2008, Volume: 58, Issue:7 Topics: Animals; Antimutagenic Agents; Arthritis; Blotting, Western; Catechin; Cell Differentiation; Disease Models, Animal; Down-Regulation; Gene Expression; Humans; Mice; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Reverse Transcriptase Polymerase Chain Reaction	2008
Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production. Proceedings of the National Academy of Sciences of the United States of America, 2008, Sep-23, Volume: 105, Issue:38 Topics: Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Catechin; Cells, Cultured; Cytokine Receptor gp130; Cytokines; Disease Models, Animal; Female; Fibroblasts; Gene Expression Regulation; Humans; Interleukin-1beta; Interleukin-6; Matrix Metalloproteinase 2; Rats; Rats, Inbred Lew; Receptors, Interleukin-6; Synovial Membrane; Up-Regulation	2008
Effects of oral consumption of the green tea polyphenol EGCG in a murine model for human Sjogren's syndrome, an autoimmune disease. Life sciences, 2008, Oct-24, Volume: 83, Issue:17-18 Topics: Administration, Oral; Animals; Antibodies, Antinuclear; Apoptosis; Catechin; Diabetes Mellitus, Type 1; Disease Models, Animal; Female; Humans; Ki-67 Antigen; Lymphocytes; Mice; Mice, Inbred NOD; Phytotherapy; Proliferating Cell Nuclear Antigen; Sjogren's Syndrome; Submandibular Gland; Tea	2008
Chemoprevention of fibroid tumors by [-]-epigallocatechin-3-gallate in quail. Nutrition research (New York, N.Y.), 2008, Volume: 28, Issue:2 Topics: Animals; Anticarcinogenic Agents; Bird Diseases; Catechin; Coturnix; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Leiomyoma; Oviducts; Random Allocation; Uterine Neoplasms	2008
EGCG inhibits proliferation of cardiac fibroblasts in rats with cardiac hypertrophy. Planta medica, 2009, Volume: 75, Issue:2 Topics: Angiotensin II; Animals; Antioxidants; Atrial Natriuretic Factor; Camellia sinensis; Cardiomegaly; Catechin; Cell Proliferation; Disease Models, Animal; DNA-Binding Proteins; Dose-Response Relationship, Drug; Endothelins; Enzyme Inhibitors; Fibroblasts; Fibrosis; Hydroxyproline; Male; Myocardium; Nitric Oxide Synthase Type II; Nitrites; Organ Size; Plant Extracts; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Transcription Factors	2009
An extract of green tea, epigallocatechin-3-gallate, reduces periapical lesions by inhibiting cysteine-rich 61 expression in osteoblasts. Journal of endodontics, 2009, Volume: 35, Issue:2 Topics: Alveolar Bone Loss; Animals; Antioxidants; Catechin; Cell Line, Tumor; Chemokine CCL2; Chemotaxis, Leukocyte; Cysteine-Rich Protein 61; Disease Models, Animal; Humans; Oncostatin M; Osteoblasts; Periapical Periodontitis; Plant Extracts; Rats; Rats, Wistar; Tea	2009
Epigallocatechin-3-gallate attenuates cardiac hypertrophy in hypertensive rats in part by modulation of mitogen-activated protein kinase signals. Clinical and experimental pharmacology & physiology, 2009, Volume: 36, Issue:9 Topics: Animals; Antioxidants; Atrial Natriuretic Factor; Catalase; Catechin; Disease Models, Animal; DNA, Mitochondrial; Electron Transport Chain Complex Proteins; Enzyme Activation; Glutathione Peroxidase; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Male; Malondialdehyde; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mitochondria, Heart; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinases; Myocardium; Myosin Heavy Chains; Natriuretic Peptide, Brain; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Superoxide Dismutase; Transcription Factor AP-1	2009
Effect of lycopene and epigallocatechin-3-gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: a novel nitric oxide mechanism. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2009, Volume: 47, Issue:10 Topics: Animals; Brain; Carotenoids; Catechin; Disease Models, Animal; Glutathione; Huntington Disease; Lycopene; Male; Maze Learning; Memory Disorders; Neuroprotective Agents; Nitric Oxide; Oxidative Stress; Rats	2009
Epigallocatechin gallate ameliorates chronic fatigue syndrome in mice: behavioral and biochemical evidence. Behavioural brain research, 2009, Dec-28, Volume: 205, Issue:2 Topics: Animals; Antioxidants; Brucella abortus; Catalase; Catechin; Disease Models, Animal; Fatigue Syndrome, Chronic; Glutathione; Hyperalgesia; Lipid Peroxidation; Lipopolysaccharides; Locomotion; Mice; Mice, Inbred Strains; Nitrites; Oxidative Stress; Superoxide Dismutase; Swimming; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha	2009
Inhibition of cyclooxygenase-2 expression and prostaglandin E2 production in chondrocytes by avocado soybean unsaponifiables and epigallocatechin gallate. Osteoarthritis and cartilage, 2010, Volume: 18, Issue:2 Topics: Aggrecans; Animals; Antioxidants; Cartilage, Articular; Catechin; Chondrocytes; Collagen Type II; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Gene Expression; Glycine max; Horses; Interleukin-1beta; NF-kappa B; Persea; Phenotype; Plant Extracts; Polymerase Chain Reaction; RNA; Tumor Necrosis Factor-alpha	2010
Protective effects of epigallocatechin gallate following 3-nitropropionic acid-induced brain damage: possible nitric oxide mechanisms. Psychopharmacology, 2009, Volume: 207, Issue:2 Topics: Animals; Antioxidants; Behavior, Animal; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mitochondria; Motor Activity; Neurodegenerative Diseases; Neuroprotective Agents; Neurotoxicity Syndromes; Neurotoxins; Nitric Oxide; Nitro Compounds; Oxidative Stress; Propionates; Rats; Rats, Wistar	2009
Regulatory effect of epigallocatechin gallate on the expression of C-reactive protein and other inflammatory markers in an experimental model of atherosclerosis. Chemico-biological interactions, 2010, Jan-05, Volume: 183, Issue:1 Topics: Animals; Aorta, Thoracic; Atherosclerosis; Biomarkers; Blood Sedimentation; C-Reactive Protein; Catechin; Diet, Atherogenic; Disease Models, Animal; Inflammation; Injections, Intraperitoneal; Lymphocyte Count; Male; Platelet Count; Rats; Rats, Wistar	2010
The effect of epigallocatechin gallate on lipopolysaccharide-induced acute lung injury in a murine model. Inflammation, 2010, Volume: 33, Issue:2 Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; Catechin; Cell Line; Chemokine CXCL2; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Lung; Macrophages; Male; Mice; Mice, Inbred ICR; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neutrophil Infiltration; Organ Size; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Severity of Illness Index; Tumor Necrosis Factor-alpha	2010
(-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma. Breast cancer research : BCR, 2010, Volume: 12, Issue:1 Topics: Animals; Apoptosis; Catechin; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; Female; Heat-Shock Proteins; Humans; JNK Mitogen-Activated Protein Kinases; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Paclitaxel	2010
Protective effect of epigallocatechin gallate in murine water-immersion stress model of chronic fatigue syndrome. Basic & clinical pharmacology & toxicology, 2010, Volume: 106, Issue:6 Topics: Administration, Oral; Animals; Antioxidants; Brain; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Fatigue Syndrome, Chronic; Mice; Oxidative Stress; Spleen; Swimming; Thymus Gland; Tumor Necrosis Factor-alpha	2010
Low dosage of rasagiline and epigallocatechin gallate synergistically restored the nigrostriatal axis in MPTP-induced parkinsonism. Neuro-degenerative diseases, 2010, Volume: 7, Issue:4 Topics: Animals; Antioxidants; Catechin; Cell Line; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Indans; Male; Mice; Mice, Inbred C57BL; Neural Pathways; Neuroprotective Agents; Parkinsonian Disorders; Recovery of Function; Substantia Nigra; Treatment Outcome	2010
The functional effect of epigallocatechin gallate on ischemic stroke in rats. Acta neurobiologiae experimentalis, 2010, Volume: 70, Issue:1 Topics: Animals; Behavior, Animal; Brain Infarction; Catechin; Disease Models, Animal; Hindlimb; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Sensory Gating; Statistics, Nonparametric	2010
Epigallocatechin-3-gallate ameliorates hyperglycemia-induced embryonic vasculopathy and malformation by inhibition of Foxo3a activation. American journal of obstetrics and gynecology, 2010, Volume: 203, Issue:1 Topics: Animals; Antioxidants; Blotting, Western; Catechin; Disease Models, Animal; Embryonic Development; Female; Fetus; Forkhead Box Protein O3; Forkhead Transcription Factors; Hyperglycemia; In Vitro Techniques; Oxidative Stress; Phosphorylation; Pregnancy; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Yolk Sac	2010
Neuroprotective effects of Epigallocatechin-3-gallate (EGCG) in optic nerve crush model in rats. Neuroscience letters, 2010, Jul-19, Volume: 479, Issue:1 Topics: Animals; Catechin; Cell Count; Cell Survival; Disease Models, Animal; Female; Nerve Crush; Neurofilament Proteins; Neuroprotective Agents; Optic Nerve Injuries; Random Allocation; Rats; Rats, Wistar; Retina; Retinal Ganglion Cells; Time Factors; Treatment Outcome	2010
Inhibition of inducible nitric oxide synthase expression and cell death by (-)-epigallocatechin-3-gallate, a green tea catechin, in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2010, Volume: 17, Issue:9 Topics: Animals; Catechin; Cell Death; Disease Models, Animal; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Nitric Oxide Synthase Type II; Parkinsonian Disorders; Tea	2010
(-)-Epigallocatechin-3-O-gallate (EGCG) reverses caffeine-induced anxiogenic-like effects. Neuroscience letters, 2010, Sep-06, Volume: 481, Issue:2 Topics: Animals; Anxiety; Caffeine; Catechin; Central Nervous System Stimulants; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Male; Maze Learning; Mice; Mice, Inbred ICR; Neuroprotective Agents; Rats; Rats, Wistar; Spectrum Analysis	2010
Amelioration of functional, biochemical and molecular deficits by epigallocatechin gallate in experimental model of alcoholic neuropathy. European journal of pain (London, England), 2011, Volume: 15, Issue:3 Topics: Alcoholic Neuropathy; Analysis of Variance; Animals; Behavior, Animal; Catechin; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Hyperalgesia; Male; Oxidative Stress; Physical Stimulation; Rats; Rats, Wistar; Urokinase-Type Plasminogen Activator	2011
[Protective activity of different concentration of tea polyphenols and its major compound EGCG against whole body irradiation-induced injury in mice]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2010, Volume: 35, Issue:10 Topics: Animals; Camellia sinensis; Catechin; Disease Models, Animal; Female; Flavonoids; Humans; Male; Mice; Phenols; Plant Extracts; Polyphenols; Radiation Injuries; Radiation-Protective Agents; Random Allocation; Superoxide Dismutase; Whole-Body Irradiation	2010
EGCG functions through estrogen receptor-mediated activation of ADAM10 in the promotion of non-amyloidogenic processing of APP. FEBS letters, 2010, Oct-08, Volume: 584, Issue:19 Topics: ADAM Proteins; ADAM10 Protein; Alzheimer Disease; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Catechin; Cell Line; Disease Models, Animal; Estrogen Receptor alpha; Female; Furin; Humans; Membrane Proteins; Mice; Models, Biological; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Signal Transduction	2010
Supplementation of green tea catechins in dentifrices suppresses gingival oxidative stress and periodontal inflammation. Archives of oral biology, 2011, Volume: 56, Issue:1 Topics: Alveolar Bone Loss; Animals; Antioxidants; Camellia sinensis; Catechin; Connective Tissue; Dentifrices; Disease Models, Animal; Epithelial Attachment; Gingiva; Gingival Recession; Lipid Peroxidation; Lysine; Male; NF-kappa B; Oxidative Stress; Periodontitis; Random Allocation; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha; Tyrosine	2011
Cardioprotective effects of epigallocatechin-3-gallate against doxorubicin-induced cardiomyocyte injury. European journal of pharmacology, 2011, Feb-10, Volume: 652, Issue:1-3 Topics: Animals; Antioxidants; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Doxorubicin; Male; Myocytes, Cardiac; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species	2011
Green tea epigallocatechin gallate enhances therapeutic efficacy of temozolomide in orthotopic mouse glioblastoma models. Cancer letters, 2011, Mar-28, Volume: 302, Issue:2 Topics: Animals; Antineoplastic Agents, Alkylating; Brain Neoplasms; Camellia sinensis; Catechin; Cell Line, Tumor; Dacarbazine; Disease Models, Animal; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; Glioblastoma; Humans; Immunohistochemistry; Mice; Mice, Knockout; Temozolomide	2011
Epigallocatechin-3-gallate reduces airway inflammation in mice through binding to proinflammatory chemokines and inhibiting inflammatory cell recruitment. Journal of immunology (Baltimore, Md. : 1950), 2011, Mar-15, Volume: 186, Issue:6 Topics: Animals; Binding Sites; Catechin; Cell Migration Inhibition; Cells, Cultured; Chemokine CXCL10; Chemokine CXCL11; Chemokine CXCL9; Chemokines; Disease Models, Animal; Inflammation Mediators; Lung; Male; Mice; Mice, Inbred BALB C; Mice, SCID; Mice, Transgenic	2011
Epigallocatechin gallate accelerates healing of indomethacin-induced stomach ulcers in mice. Pharmacological reports : PR, 2011, Volume: 63, Issue:2 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antioxidants; Catechin; Disease Models, Animal; Gastric Mucosa; Indomethacin; Lipid Peroxidation; Male; Mice; Omeprazole; Oxidative Stress; Stomach Ulcer; Tea	2011
Chemopreventive effect of epigallocatechin-3-gallate (EGCG) and folic acid on the N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced gastrointestinal cancer in rat model. Journal of digestive diseases, 2011, Volume: 12, Issue:3 Topics: Adenocarcinoma; Administration, Oral; Animals; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Proliferation; Disease Models, Animal; Drug Therapy, Combination; Folic Acid; Gastrointestinal Neoplasms; Hematinics; Male; Methylnitronitrosoguanidine; Rats; Rats, Wistar; Sarcoma; Treatment Outcome	2011
A comparative study of the inhibiting effects of mitomycin C and polyphenolic catechins on tumor cell implantation/growth in a rat bladder tumor model. The Journal of urology, 2011, Volume: 186, Issue:2 Topics: Animals; Antibiotics, Antineoplastic; Anticarcinogenic Agents; Catechin; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Screening Assays, Antitumor; Female; Mitomycin; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms	2011
Effects of green tea polyphenol (-)-epigallocatechin-3-gallate on newly developed high-fat/Western-style diet-induced obesity and metabolic syndrome in mice. Journal of agricultural and food chemistry, 2011, Nov-09, Volume: 59, Issue:21 Topics: Animals; Blood Glucose; Body Weight; Catechin; Diet, High-Fat; Disease Models, Animal; Humans; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Obesity; Plant Extracts; Polyphenols	2011
Effects of topical application of EGCG on testosterone-induced hair loss in a mouse model. Experimental dermatology, 2011, Volume: 20, Issue:12 Topics: 17-Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases; Alopecia; Animals; Antioxidants; Apoptosis; Catechin; Cyproterone Acetate; Dihydrotestosterone; Disease Models, Animal; Down-Regulation; Epithelial Cells; Female; Hair; Hair Follicle; Mice; Mice, Inbred CBA; Receptors, Androgen; Sebaceous Glands; Testosterone	2011
Therapeutic efficacy of topical epigallocatechin gallate in murine dry eye. Cornea, 2011, Volume: 30, Issue:12 Topics: Animals; Antioxidants; Catechin; Chemokines; Cornea; Disease Models, Animal; Dry Eye Syndromes; Female; Fluorescein; Immunohistochemistry; Interleukin-1beta; Mice; Mice, Inbred C57BL; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor D	2011
Neuroprotection of green tea catechins on surgical menopause-induced overactive bladder in a rat model. Menopause (New York, N.Y.), 2012, Volume: 19, Issue:3 Topics: Animals; Catechin; Disease Models, Animal; Female; Menopause; Neuroprotective Agents; Ovariectomy; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Tea; Urinary Bladder, Overactive	2012
Role of neuronal nitric oxide synthase in the antiallodynic effects of intrathecal EGCG in a neuropathic pain rat model. Neuroscience letters, 2012, Feb-21, Volume: 510, Issue:1 Topics: Animals; Arginine; Catechin; Disease Models, Animal; Extremities; Hyperalgesia; Injections, Spinal; Ligation; Male; Neuralgia; Nitric Oxide; Nitric Oxide Synthase Type I; Rats; Rats, Sprague-Dawley; Spinal Cord; Spinal Nerves	2012
Epigallocatechin-3-gallate as a potential therapeutic drug for TTR-related amyloidosis: "in vivo" evidence from FAP mice models. PloS one, 2012, Volume: 7, Issue:1 Topics: Amyloid; Amyloid Neuropathies, Familial; Animals; Biomarkers; Catechin; Colon; Disease Models, Animal; Endoplasmic Reticulum Stress; Gastric Mucosa; Humans; Mice; Mice, Transgenic; Peripheral Nervous System; Prealbumin; Stomach	2012
Quantitative evaluation of the beneficial effects in the mdx mouse of epigallocatechin gallate, an antioxidant polyphenol from green tea. Histochemistry and cell biology, 2012, Volume: 137, Issue:6 Topics: Animals; Antioxidants; Body Weight; Catechin; Disease Models, Animal; Eating; Female; Male; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscular Dystrophy, Duchenne; Oxidative Stress; Polyphenols; Tea	2012
Green tea catechins decrease oxidative stress in surgical menopause-induced overactive bladder in a rat model. BJU international, 2012, Volume: 110, Issue:6 Pt B Topics: Animals; Antioxidants; Catechin; Disease Models, Animal; Female; Menopause; Ovariectomy; Oxidative Stress; Plant Extracts; Rats; Rats, Sprague-Dawley; Tea; Urinary Bladder, Overactive	2012
Deleterious effects of high concentrations of (-)-epigallocatechin-3-gallate and atorvastatin in mice with colon inflammation. Nutrition and cancer, 2012, Volume: 64, Issue:6 Topics: Animals; Atorvastatin; Azoxymethane; Catechin; Colitis; Colon; Colonic Neoplasms; Dextran Sulfate; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gastrointestinal Hemorrhage; Heptanoic Acids; Leukotriene B4; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Pyrroles; Rectum; Weight Loss	2012
Beneficial effects of (-)-epigallocatechin gallate on ischemia-reperfusion testicular injury in rats. Journal of pediatric surgery, 2012, Volume: 47, Issue:7 Topics: Animals; Antioxidants; Biomarkers; Catechin; Disease Models, Animal; Male; Postoperative Complications; Random Allocation; Rats; Rats, Wistar; Reperfusion Injury; Spermatic Cord Torsion	2012
A modulating effect of epigallocatechin gallate (EGCG), a tea catechin, on the bladder of rats exposed to water avoidance stress. Neurourology and urodynamics, 2013, Volume: 32, Issue:3 Topics: Animals; Catechin; Cell Degranulation; Cystitis, Interstitial; Defecation; Disease Models, Animal; Female; Immersion; Injections, Intraperitoneal; Mast Cells; Rats; Rats, Sprague-Dawley; Stress, Psychological; Time Factors; Urinary Bladder; Urination; Water	2013
Epigallocatechin-3-gallate modulates antioxidant and DNA repair-related proteins in exocrine glands of a primary Sjogren's syndrome mouse model prior to disease onset. Autoimmunity, 2012, Volume: 45, Issue:7 Topics: Animals; Antibodies, Antinuclear; Antioxidants; Catechin; Disease Models, Animal; DNA Repair; Exocrine Glands; Female; Lymphocytes; Mice; Mice, Inbred NOD; Peroxiredoxin VI; Proliferating Cell Nuclear Antigen; Sjogren's Syndrome; Time Factors	2012
Epigallocatechin-3-gallate prevents systemic inflammation-induced memory deficiency and amyloidogenesis via its anti-neuroinflammatory properties. The Journal of nutritional biochemistry, 2013, Volume: 24, Issue:1 Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Astrocytes; Behavior, Animal; Catechin; Cells, Cultured; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Inflammation; Lipopolysaccharides; Male; Memory Disorders; Mice; Mice, Inbred ICR; Neurons; Nitric Oxide Synthase Type II; Peptide Fragments; Rats	2013
Combination therapy with taurine, epigallocatechin gallate and genistein for protection against hepatic fibrosis induced by alcohol in rats. Biological & pharmaceutical bulletin, 2012, Volume: 35, Issue:10 Topics: Actins; Alanine Transaminase; Alkaline Phosphatase; Animals; Antioxidants; Aspartate Aminotransferases; Catechin; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Ethanol; gamma-Glutamyltransferase; Genistein; Liver Cirrhosis; Peroxidase; Proto-Oncogene Proteins c-bcl-2; Rats; RNA, Messenger; Smad3 Protein; Taurine	2012
Natural therapies assessment for the treatment of endometriosis. Human reproduction (Oxford, England), 2013, Volume: 28, Issue:1 Topics: Angiogenesis Inhibitors; Animals; Antioxidants; Apoptosis; Catechin; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Endometriosis; Endometrium; Female; Humans; Injections, Intraperitoneal; Intestinal Diseases; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Random Allocation; Resveratrol; Stilbenes	2013
Green tea extract reverses endothelial dysfunction and reduces atherosclerosis progression in homozygous knockout low-density lipoprotein receptor mice. Nutrition research (New York, N.Y.), 2012, Volume: 32, Issue:9 Topics: Alanine Transaminase; Animals; Antioxidants; Aorta; Atherosclerosis; Biomarkers; Catechin; Chemokine CCL2; Disease Models, Animal; Endothelium, Vascular; Female; Inflammation; Lipoproteins, LDL; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Plant Extracts; Receptors, LDL; Tea; Triglycerides; Tumor Necrosis Factor-alpha	2012
EGCG inhibits CTGF expression via blocking NF-κB activation in cardiac fibroblast. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2013, Jan-15, Volume: 20, Issue:2 Topics: Animals; Catechin; Cell Proliferation; Cells, Cultured; Collagen; Connective Tissue Growth Factor; Disease Models, Animal; Fibroblasts; Fibronectins; Fibrosis; Gene Expression Regulation, Neoplastic; Humans; Male; Myocardium; NF-kappa B; Plant Extracts; Rats; Rats, Sprague-Dawley; Tea	2013
Neuroprotective effect of (-)-epigallocatechin-3-gallate in rats when administered pre- or post-traumatic brain injury. Journal of neural transmission (Vienna, Austria : 1996), 2013, Volume: 120, Issue:5 Topics: 8-Hydroxy-2'-Deoxyguanosine; Aldehydes; Animals; Brain Edema; Brain Injuries; Catechin; Deoxyguanosine; Disease Models, Animal; DNA, Single-Stranded; Drug Administration Schedule; Glial Fibrillary Acidic Protein; Lipid Peroxidation; Male; Maze Learning; Neurons; Neuroprotective Agents; Phosphopyruvate Hydratase; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Time Factors	2013
Therapeutic potential of EGCG on acute renal damage in a rat model of obstructive nephropathy. Molecular medicine reports, 2013, Volume: 7, Issue:4 Topics: Acute Kidney Injury; Animals; Antioxidants; Catechin; Disease Models, Animal; Glutathione; Glutathione Disulfide; Humans; Infusions, Parenteral; Kidney; Male; NF-E2-Related Factor 2; Oxidative Stress; Rats; Reactive Oxygen Species; Signal Transduction	2013
Inhibitory effects of epigallocatechin-3-gallate on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in F344 rats. International journal of oncology, 2002, Volume: 21, Issue:6 Topics: Animals; Anticarcinogenic Agents; Catechin; Cyclin D1; Cyclooxygenase 1; Cyclooxygenase 2; Dimethylnitrosamine; Dinoprostone; Disease Models, Animal; DNA Primers; Enzyme-Linked Immunosorbent Assay; Esophageal Neoplasms; Esophagus; Isoenzymes; Male; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Urokinase-Type Plasminogen Activator	2002
Effects of delayed administration of (-)-epigallocatechin gallate, a green tea polyphenol on the changes in polyamine levels and neuronal damage after transient forebrain ischemia in gerbils. Brain research bulletin, 2003, Aug-30, Volume: 61, Issue:4 Topics: Animals; Antioxidants; Brain Chemistry; Catechin; Cell Survival; Chromatography, High Pressure Liquid; Disease Models, Animal; Flavonoids; Gerbillinae; Hippocampus; Ischemic Attack, Transient; Male; Phenols; Polyamines; Polymers; Prosencephalon; Time Factors	2003
Epigallocatechin gallate can significantly decrease free oxygen radicals in the reperfusion injury in vivo. Transplantation proceedings, 2003, Volume: 35, Issue:8 Topics: Animals; Antioxidants; Catechin; Disease Models, Animal; Femoral Artery; Femoral Vein; Kinetics; Male; Muscle, Skeletal; Rats; Rats, Wistar; Reperfusion Injury; Superoxides	2003
Prostate carcinoma and green tea: (-)epigallocatechin-3-gallate inhibits inflammation-triggered MMP-2 activation and invasion in murine TRAMP model. International journal of cancer, 2004, Dec-10, Volume: 112, Issue:5 Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Inflammation; Male; Matrix Metalloproteinase 2; Mice; Neoplasm Invasiveness; Prostatic Neoplasms; Tea	2004
Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate. Journal of molecular neuroscience : MN, 2004, Volume: 24, Issue:3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Synuclein; Animals; Apomorphine; Catechin; Disease Models, Animal; Free Radicals; Iron; Iron Chelating Agents; Lewy Bodies; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neuroprotective Agents; Oxidative Stress; Parkinsonian Disorders; Substantia Nigra; Synucleins; Ubiquitin	2004
Short-term administration of (-)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2005, Volume: 11, Issue:3 Topics: Animals; Antioxidants; Body Weight; Catechin; Disease Models, Animal; Energy Intake; Energy Metabolism; Fatty Liver; Hepatocytes; Liver; Liver Circulation; Male; Mice; Mice, Obese; Necrosis; Reperfusion Injury	2005
Black tea extract can modulate protein expression of H-ras, c-Myc, p53, and Bcl-2 genes during pulmonary hyperplasia, dysplasia, and carcinoma in situ. Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer, 2005, Volume: 24, Issue:3 Topics: Animals; Animals, Newborn; Anticarcinogenic Agents; Apoptosis; Benzo(a)pyrene; Biflavonoids; Carcinoma in Situ; Catechin; Cell Proliferation; Disease Models, Animal; Female; Gene Expression Regulation, Neoplastic; Hyperplasia; Lung; Lung Neoplasms; Male; Mice; Plant Extracts; Proto-Oncogene Proteins; Proto-Oncogenes; Tea	2005
The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice. Neuroscience letters, 2006, Mar-06, Volume: 395, Issue:2 Topics: Amyotrophic Lateral Sclerosis; Animals; Blotting, Western; Caspase 3; Caspases; Catechin; Disease Models, Animal; Disease Progression; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Mice; Mice, Transgenic; Motor Activity; Mutation; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1	2006
Green tea extract and its major polyphenol (-)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy. American journal of physiology. Cell physiology, 2006, Volume: 290, Issue:2 Topics: Animals; Antioxidants; Camellia sinensis; Catechin; Diet; Disease Models, Animal; Free Radical Scavengers; Humans; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle Contraction; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Pentoxifylline; Phytotherapy; Plant Extracts; Plant Preparations	2006
The repressive effect of green tea ingredients on amyloid precursor protein (APP) expression in oral carcinoma cells in vitro and in vivo. Cancer letters, 2007, Jan-08, Volume: 245, Issue:1-2 Topics: Amyloid beta-Protein Precursor; Animals; Blotting, Western; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Mesocricetus; Mouth Mucosa; Mouth Neoplasms; Phytotherapy; Plant Preparations; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tea	2007
Epigallocatechin-3-gallate protects toluene diisocyanate-induced airway inflammation in a murine model of asthma. FEBS letters, 2006, Mar-20, Volume: 580, Issue:7 Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Catechin; Disease Models, Animal; Gene Expression Regulation; Inflammation; Interleukin-5; Matrix Metalloproteinase 9; Mice; Reactive Oxygen Species; Respiratory System; Toluene 2,4-Diisocyanate; Tumor Necrosis Factor-alpha	2006
Epigallocatechin-3-gallate reduces allergen-induced asthma-like reaction in sensitized guinea pigs. The Journal of pharmacology and experimental therapeutics, 2006, Volume: 317, Issue:3 Topics: Allergens; Animals; Anti-Asthmatic Agents; Asthma; Bronchoalveolar Lavage Fluid; Catechin; Disease Models, Animal; Guinea Pigs; Lung; Male; Nitric Oxide Synthase; Ovalbumin	2006
Anxiolytic properties of green tea polyphenol (-)-epigallocatechin gallate (EGCG). Brain research, 2006, Sep-19, Volume: 1110, Issue:1 Topics: Animals; Anti-Anxiety Agents; Anxiety; Avoidance Learning; Behavior, Animal; Carbolines; Catechin; Cells, Cultured; Chlordiazepoxide; Convulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Electroshock; Embryo, Mammalian; gamma-Aminobutyric Acid; Hippocampus; Male; Maze Learning; Membrane Potentials; Mice; Neurons; Patch-Clamp Techniques; Reaction Time	2006
Polyphenol (-)-epigallocatechin gallate protection from ischemia/reperfusion-induced renal injury in normotensive and hypertensive rats. Transplantation proceedings, 2006, Volume: 38, Issue:7 Topics: Animals; Blood Urea Nitrogen; Catechin; Creatinine; Disease Models, Animal; Flavonoids; Hypertension; Phenols; Polyphenols; Rats; Rats, Inbred SHR; Reference Values; Renal Circulation; Reperfusion Injury	2006
Neuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis. Neurochemical research, 2006, Volume: 31, Issue:10 Topics: Amyotrophic Lateral Sclerosis; Animals; Blotting, Western; Caspase 3; Catechin; Disease Models, Animal; Enzyme Activation; Female; Immunohistochemistry; Male; Mice; Mice, Transgenic; Microglia; Motor Neurons; Neuroprotective Agents; NF-kappa B	2006
Protective effects of EGCg or GCg, a green tea catechin epimer, against postischemic myocardial dysfunction in guinea-pig hearts. Life sciences, 2007, Feb-20, Volume: 80, Issue:11 Topics: Animals; Antioxidants; Apoptosis; Calcium; Caspase 3; Catechin; Disease Models, Animal; Electron Spin Resonance Spectroscopy; Female; Guinea Pigs; Heart; Heart Ventricles; In Vitro Techniques; Male; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Reperfusion Injury; Myocardium; Perfusion; Reactive Oxygen Species	2007
Green tea polyphenols reduce autoimmune symptoms in a murine model for human Sjogren's syndrome and protect human salivary acinar cells from TNF-alpha-induced cytotoxicity. Autoimmunity, 2007, Volume: 40, Issue:2 Topics: Animals; Autoimmunity; Catechin; Cell Line; Cell Survival; Disease Models, Animal; Flavonoids; Humans; Imidazoles; Lymphocytes; MAP Kinase Kinase 4; MAP Kinase Kinase Kinases; Mice; Mice, Inbred NOD; p38 Mitogen-Activated Protein Kinases; Phenols; Phosphorylation; Plant Extracts; Polyphenols; Pyridines; Salivary Glands; Sjogren's Syndrome; Tea; Tumor Necrosis Factor-alpha	2007
Green tea polyphenol epigallocatechin-3-gallate inhibits oxidative damage and preventive effects on carbon tetrachloride-induced hepatic fibrosis. The Journal of nutritional biochemistry, 2007, Volume: 18, Issue:12 Topics: Animals; Beverages; Carbon Tetrachloride Poisoning; Catechin; Cell Culture Techniques; Disease Models, Animal; Disease Progression; Enzyme Activation; Liver; Liver Cirrhosis; Male; Matrix Metalloproteinase 2; Rats; Rats, Sprague-Dawley; Rats, Wistar	2007
The green tea polyphenol epigallocatechin-3-gallate improves systemic hemodynamics and survival in rodent models of polymicrobial sepsis. Shock (Augusta, Ga.), 2007, Volume: 28, Issue:3 Topics: Animals; Blood Pressure; Catechin; Disease Models, Animal; Gene Expression; Lung; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Nitrates; Nitric Oxide Synthase Type II; Nitrites; Rats; Rats, Sprague-Dawley; Sepsis; Survival Rate	2007
Neuroprotective effects of quercetin and rutin on spatial memory impairment in an 8-arm radial maze task and neuronal death induced by repeated cerebral ischemia in rats. Journal of pharmacological sciences, 2007, Volume: 104, Issue:4 Topics: Animals; Brain Ischemia; Catechin; Cell Death; Disease Models, Animal; Flavonoids; Hippocampus; Male; Maze Learning; Memory; Neurons; Neuroprotective Agents; Quercetin; Rats; Rats, Wistar; Rutin; Space Perception; Structure-Activity Relationship	2007
Trypanosoma cruzi: in vitro and in vivo antiproliferative effects of epigallocatechin gallate (EGCg). Experimental parasitology, 2007, Volume: 117, Issue:2 Topics: Animals; Antioxidants; Catechin; Chagas Disease; Disease Models, Animal; DNA Fragmentation; Dose-Response Relationship, Drug; Hepatocytes; In Situ Nick-End Labeling; Male; Mice; Mice, Inbred BALB C; Parasitemia; Random Allocation; Trypanocidal Agents; Trypanosoma cruzi	2007
Epigallocatechin gallate attenuates experimental non-alcoholic steatohepatitis induced by high fat diet. Journal of gastroenterology and hepatology, 2008, Volume: 23, Issue:8 Pt 2 Topics: Animals; Antioxidants; Catechin; Diet; Dietary Fats; Disease Models, Animal; Fatty Liver; Liver; Male; Rats; Rats, Sprague-Dawley	2008
Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis. European journal of pharmacology, 2008, Jan-28, Volume: 579, Issue:1-3 Topics: Animals; Antioxidants; Catechin; Colitis; Cytokines; Disease Models, Animal; Injections, Intraperitoneal; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; NF-kappa B; Peroxidase; Tea; Transcription Factor AP-1; Trinitrobenzenesulfonic Acid	2008
[Protective effect of epigallocatechin-3-gallate on inflammatory bowel disease: experiment with rat models of induced colitis]. Zhonghua yi xue za zhi, 2007, Nov-13, Volume: 87, Issue:42 Topics: Animals; Blotting, Western; Catechin; Cyclooxygenase 2; Disease Models, Animal; Gene Expression; Inflammatory Bowel Diseases; Intestinal Mucosa; Random Allocation; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Trinitrobenzenesulfonic Acid	2007
Preventive effect of (-)epigallocatechin-gallate (EGCG) on lysosomal enzymes in heart and subcellular fractions in isoproterenol-induced myocardial infarcted Wistar rats. Chemico-biological interactions, 2008, Apr-15, Volume: 172, Issue:3 Topics: Animals; Cardiovascular Agents; Catechin; Disease Models, Animal; Heart; Isoproterenol; Lysosomes; Male; Myocardial Infarction; Rats; Rats, Wistar; Subcellular Fractions; Time Factors	2008
The beneficial effect of (-)-epigallocatechin-3-gallate in an experimental model of Alzheimer's disease in rat: a behavioral analysis. Iranian biomedical journal, 2007, Volume: 11, Issue:4 Topics: Alzheimer Disease; Animals; Catechin; Disease Models, Animal; Male; Maze Learning; Psychomotor Performance; Rats; Rats, Wistar	2007
Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain research, 2008, Jun-12, Volume: 1214 Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Catechin; Cognition Disorders; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Maze Learning; Mice; Mice, Transgenic; Mutation; Neuroprotective Agents; Phosphorylation; tau Proteins	2008
Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. The Journal of nutrition, 1998, Volume: 128, Issue:12 Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Anticarcinogenic Agents; Catechin; Cell Line; Disease Models, Animal; Down-Regulation; Flavonoids; Gene Expression Regulation; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Phenols; Polymers; Tea; Tumor Necrosis Factor-alpha	1998